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next ofkin could be identified for 65 (I 1%) ofthe probands and 20 (3.4%) of potential
controls refused. to participate.
To determine the original cause ofrena! disease in the probands the medical reco rds were
reviewed. The information gathered wasreviewed by a single clinical nephrologist who was
blinded to the identity of the patient. Diseases with a Mendelian patt ern ofioheritance
accounted for ESRD in 8.4% of the cases. 4.5% being autosomal domi nant polycystic kidney
disease . 2.5% Alport's syndrome and the remaining 1.4% to othe r genetic diseases. This gro up
ofcases wasexcluded from the subsequent familial risk analysis. Glom eruJonephritis wasthe
renal diagnosis in 25% of the probands, diabetes mellitus in 20%. unknown in 14%. othe r in
12%. interstitial in 11%. hypertensive scleros is in 5% and multip le causes in 4%.
Primary outcomes weredefined as a positiv e family history of renal failure associated wi th renal
replacement therapy in a first, second or third degree relative ofa proband or contro l. In the
group witho ut a Mende lian pattern of inheritance. 28% had a first, second or third degree
relative with renal failure associated with death or requiring dialysis versus 15% ofcontrols.
1.2% of first degree relatives of probandsdeveloped renal failure compared to 0.4% offirst
degree relatives of contro ls (OR -3.0. 95% CI: 1.7.5.2). No difference wasobserved in risk
for second degree relatives. but a highly significant increased risk was observed for third degree
relatives of probands (OR"'2.1. 95% CI: 1.2-3.4). The highest rate ofaffected first degree
iii
relatives occurred in relatives of probands with hypertensive nephrosclerosis (2.3%), diabetes
mellitus (1.6%) andinterstitial disease (1.6%).
The second control group utilized was theprovinciaJ population. The proportion or relatives of
probaods registered with the Canadian Organ Replacement Registry (CORR) wascompared
to the rate of the general population. The provincial incidence ofESRD, registered with
CORR. from 1981·1993 was79/million. excluding 8% or patients with Mendelian inherited
disease. The comparable rate ofESRD in first degree relatives of probands without Mendelian
inherited renal disease was297/million almost four times the provinciaJ rate. The comparable
rate for first degree relatives of controls was 135/million.
~ We conclude that not only is the contribution of Mendelian inheriteddisease to
ESRD high. but there is also an increased risk or renal Failurein first degree relatives of
probands without Mendelian inherited renal disease in a Caucasian population.
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PREAMBLE
The nephrology division in the Medical School at Memorial University has an ongoing interest in
the clinical epidemiology ofgenetic renal diseases. Casual intervie w afpatients at one afthe
Endstage renal disease (ESRD) treatm ent centres in Newfoundland indicated a number of renal
fai lure patients without a known Mendelian disorder who bad othe r relati ves rece iving som e
fonn of rena! rep lacement therapy. A descriptive study wastherefore undertaken in orde r to
detennine the prevalen ce ofESRD among patient's famil y members. Thi s study bad the overal l
goal of establishing whether there was a familial tendency for common form s o f renal disease
that had not previously been co nsidered to have a geneti c basis .
I became involved in the study during employment as an undergraduate student in the summ er
of 1994. The nephrology research unit had already made valuable resear ch gains on such
Mende lian renal diseases as Polycystic kidne y disease and Bardet-B iedl syndrome. Drs.
Patrick Parfrey . John Harn ett and l ohn Bear were the coordinators and my supervisors
th roughout the research. The research wassuppo rted by the Kidn ey Founda tion ofCanada..,
Montreal, Canada and funded by Faculty of Medicine. Memorial. Co llecti on of family histories
andmedical records wasdone by myself and research nurse Donna Heffe rten, without whose
valuable help the project would not have beencompleted. Diagnos is of primary renal disease
xi
in probands was made by nephrologist. Dr. P. Pa:rfrey . The computer andstatistical progn.m
wasset up by OW" computer consultant Dmitri Gerchikov . Statistical analysis wasdooc by
myself.
As part of my Master's work.thenatural history ofBardet-Biedl syndrome wasdescribedand
hasrecently beenpublished in the American Journal of Kidney Diseases (O'Dea et aI. 1 996~
Table E). A consequence oCour research hasbeen the collaboration with molecular
biochemists Dr. William Davidson. PhD candidate Terry Young and Masters candidate
Michael Woods who are undertaking molecular linkage studies of our families with Mendelian
renaldisease in the hopes of identifying the mutations responsible for the diseases.
xii
Chapter I
INTRODUcnON
Ll c.epctic; Eoid cmjology
MedicalgeneticstudieshavelaJ:ge/y coocentnItcd.ondisorderswhichfollowsimple patterns of
Mcndelianinheritance.,includinggeneticdisc:ascscausedbysinglegenemutatioos.sucbascystic
fibrosis. The mechanisms of manyoftbese conditions are relativelywell understood. These
disordersare rare, however.affectingonlyasmall proportion ofthc population. Manydisorders
that are both serious and frequeDt do not follow a simple mode of inheritance. Theseinclude
diseasessuchasdiabetc::s mellitus.beandiseaseand kidney diseasewhichareresponsibleforthe
majority of mcrtaIity and morbidityindeveloped countries suchas Canada. In manyof these
common diseases thereisa definite familialtc:ndency . die proportioo. of affected relativesbeing
grcatc:rthan in the genmtl popuIlttion. buI: lessthan would be expectedon • simple Mendelian
basis. Onepossible cxpIanation is tbat liabi:litytotbcscdisordersis multifaetorial, rdlectingan
intJ::rac:tiooof polygemcinl'IeIited.liability with c:nviron:mertta inf:1uenc:cs on risk. The 8SSI.mption
with polygenicinheritanceisthatthenumberofgmes is relatiYelylargeand that the contribution
ofeach to liability is small (Mueller et at 199 5).
A searc h for familial aggregation often serves as an initi al step in unravelling the genetic
epidemiologyof common diseases(Khouryct al, 1986; Wicbamartrie. 1995). Ifa familial
~ is found,the DCXlstep is an ~pt to discrimina1eamong gc:oeticand'orculnaaJ
factorstbaJ: mightbecausing thisclustering. Finally, ifevidence of a role for genetic factors is
fOund. ",",-d:s;gDod10"" fu< ,...,.;aIgeootic"""""'"'" mepofunncd (5=..aI,1907;
Wiclcramartrie, I99S) .
Thesearch for gmeticfactors whichinflu:nc:criskofcommondiseases is made moreefficient by
advances in moleculat~csandstatistical assessmenlofp:llygenic inheritance.Thissearch has
practicalimplications. Improvedknowledge of the details of genetic liability to an increasing
nwnber ofbwnan diseases leadsto refined diagnosi s. newtherapeutic approaches.,and disease
preventio n (Vogel et e l, 1979).
U Endlltlge Heftl l PilIA x · P ralle D£, I ud rou
Kidney failure is a major medical , ec:onom1cand socialproblem for patients andtheir families.
Treatment for irreversible chronicrena.I fail~ has inacaseddnmaticalJy in theJasadecade. The
Canadian JKV8.Ierx:e rate ofm:ated ESRD , ofS36 permillion Canadiansa year, is similartoOChcr
developed countries, althoughit is still lower thanthe US rate. Differences in prevalence rates
betwecndifferentcountriesisoftendifficult to interpret as it isgenerallyunknown to what extent
differences in referm.ls or acceptance for ESRD exist betweencountries. Thus a risk factor for
treated ESRD mayreflect an increased probabilityof developing kidney failure or an increased
~ forbeingtrea:tedafter kidneyfiulure badoccurn:d.Theriskofsdcction biasis grCItcit
inpopulationsinwhichtheawilabilityofESRD therapyis limited Newfoundland basthesecond
highcstratc: in thecountry, witha prewlence mte of642 persons permillion In 1993,thcnumbcr
ofCanactiansreceivingsomefonn ofrenal replacementtherapywas24,500,double that in 1983
(CORR, 1994). In the US. theprevalence rate in 1991 was721 per million persons with an
annual increaseof9C'1R between 1980 and 1991 (USRDS, 1993). There are several possible
explanationsfor the increasedprevalence rate ofESRD . Onelikelyexplanation is that fewer
peueresare leftuntreatedTherebasalso beenan improvementin the life expectancy of many
persons receivingESRDtherapy. The growing fraction of aged anddiabetic persons in the
populationalsocontnbutcs to an increase in incidenceofESRD. Peopleare living longerand
swvivingcompetingrisks. suchascoronary disease, wheretheywouldhavedied before, making
it more likely that they will go onto to renal failure.
In theUSit hasbeenestimated thatthedim;tcostofESRD therapyamounted to 8.6billiondoUars
in 1991. Besidethemonctuycostthereisalsothclwmancostofirrevemblerenal failure:marked
reductionin lifecxpectancy, increased morbidityandsubstantial lossinthequalityof lifeasa result
of the need for continuing therapy and loss of employment (USRDS. 1991).
LJ. Eyide nce (or (,mj 'iI' Ij,bjlitx to ESBD
In the US disorders with a Mendelian pattern of inheritance account for 3.3% of cases who
develop ESRD and in Canada the proportion is 6.3% (USRDS, 1994; CORR.. 1993). This
probablydoesnotrefiectatruediffcrenceintbeamountofMendeliancaseswithESRDbetween
the two countries as these proportions are dependent on the incidence and acceptance for
trcatmcnl: of patientswith otherdiseases, Thisvalueis certainly an lD1derestimatc because detailed
family histories maynot havebeen obtained from manyofthe patients enrolledin thenational
~gistrics. The genetic contnbution to ESRD in theremainingmajorityofpaticnts becom es an
importantquestion. Are genetic influencescausing a greater susceptibilityin deve lopmg renal
failure . Two questions of practicalimportance arise : What is the riskof ESRD in fustdegree
relatives? ts this risk higher than the population average?
lnadditiontoESRD occurring in families aspmof a single gene disorder,accwnulatedevidence
from family studics (Roy et al, 1971; Badcrctal, 197 4; Agar et al, 1980; Walker et al, 1982;
Kilruta etal,1983;Tnmnin ctaI, 1983; JuIianet aI, 1985; O'ConneU et al, 1987; Ram bausck et
al, 1987; Ferguson et a l, 1988; Seequistet aI, 1989; Pettitt et al, 1990; Steenland et ai, 1990;
Borch-Johnsonetal, 1992; Noe, 1992; Quinn et al, 1992; Charasseetal, 1993; Freedman et a l,
19938; Nomuraet ai, 1993; Freedman et ai, 1995A; Spray et al, 1995), HI.A marker studies
(Tolkoff-Rubin et al,1978; KJouda et al, 1979; Sabatier et al, 1979; Katz et et, 1980;
Kashiwabanlet ai, 1982; Nomoto et ai, 1984; Welc h et al, 1986; Naito et al, 1987; O'Connell
eta!, 1987;Benhouxetal. 1988; GlicklichetaJ..1988A; Hask.e lletaI. 1988; Huang. 1989; Hiki
et al, 199O", li et at.1992 ; Ogabaraet at, 1992; Clark.et al , (993; Freedm an et al, 1994A.;
Freedmanetal., 19948; Mul leretal, 1995), racial ccmpensccs (Sisson et al, 1975; Nostrandet
al, 1982; Jenene et al, 1985; Benhouxetal, 1988; Hoyetal, 1989; Hughsonetal, 1989; Hiki et
aI, 1990; Van Buyoderet al, 1993; Jacobsooet al, 1995)and animal studies (Weeni ng, 1986 ;
Bro\m et al, 1994) indicareagcneticwriation in liabilityto suchcommon renaldiseasesasdiabetic
nephropathy, glomerul onephritis, interstitial disease and hype rtensi ve renal dama ge.
Investigationoffamilial aggregation usingdetails from family pedigreesis a startingpoint for
cvaluatingtb:~oontribution to a disease.Inacktition topovidingestimar.esofrisks,&miliaI
aggregationstudies may provideclues aboutthe modeofinheritanee . Racialvariationindisease
rates povide additionalsupportivedata regarding the possible toleof genetic factorsindisease .
ArrydifferenccsiDrenaJdiseaserates~differmtpopuJarionsubgroupsmayhavc:agenctic
origin, butmayalso reflect socialclass,cultI.Dt: or interactionsof genetic susceptibi lities and
environmental ClCpOSUI'eS . It is difficult to disen tangl c the effects of these factors.
Theassociationof puticular Human leukocyteantigen(HLA) alleles with particulatdiscasc:soffers
cvidcnceforgenc:tic IiabilitytoseveraJrenaIdiseases(Silver, 1990). While somegcnetictraitsare
alwaysassociatedwith a parti cular pbeootype,other traits representgeneticvariation present in
individualswbich may confi:rincn:asc:d~toccrtain diseases. Differett HlAantigens
mayexistin~disequilibriumwithgenescausing~renal scaninginpatic:rroiwt1b
\/llriousrenaJ.diseasetypeS. Thereappcarto be5C\'ml.ldiseasesuscepbbility genc:softhemajor
~oomplcxdmba",,__ Th=oud>:ssuggestdmthe"""""'Hu.
allele identifiessusceptib le individuals who will deve lop the disease only after appropriate
environmema.l exposure. Some ofthe HI.A associationswi th renaldisease such as idiopathic
_"""""""',~_gIomeruJon<pIui lgA"""""""' ''''''''''ux
nephropathy are equally as strong or strongerthan thosefound with such well studied diseasesas
rheuma toid arthriti s and diabete s (C lade et al, 1993).
Themajorairnofthe present investigation wastbeestabl ishmentofa more accurateas.sc:ssment
of risk. for the development of renal failure ofprobandsari sing from a defined Ca ucasian
pop.dation.Themajorstrengthsof1heaJllmtstudycompll'Cl1tothcsep-eviousinYestigationsare
the.",of the popdatioo studi<d, the """"""'"'""""""""of the"""" popdatioo (e.uoo.w.
ofAngIG-lrishdesa:nt), and the nature of the controlgroupsutilized Previous investigators
em ployed age and sex matched controls selected from the general population or a hospital
population ThisirMstigationhasused spousalcontrol subjc:clS which,as will be discussed, offer
several potential advanta ges and also used the provincial population as a contro l.
UJ. famili a' d,b (or , peejfl£ rep a' diM nieD
1.3.1.1 Glo merulonephritis
A growing bodyof evidence suggem thepossibilityof a genetic susce pti bil ity to glomerular
damage. AfiicanAmericans arefour times as likelyaswhiteAmericansto developESROdueto
g1omeruionephritis(USRDS.I993). ESRDsccondarytogiomeruionephritis(GN)isincreasing
in frequency amongnativeAmcricanIndiam(Hoyctal. 1989;Hugbsonetat, 1989) andAustralian
Aborigines(Van Buynderet at, 1993). In an investigationof an island Aboriginalcommunity ,
p-oteinuria, glomerularhematuriaandESRDwere foundto befamilial (Van Buytderet at,1993);
theincidcnceofESRDin thiscommunitywas greaterthaninothercommunities livinginsimilar
environmental conditions. Theseinvestigators inferred that glomerular rena l disease in this
poprlariOl1rcsultedfiomenvironmerdalfilctorsinteractingwithastronggcneUcpt:d:isposition(Van
Buyndcrctol,1993). Familialmkfocglomerolonepbritishasabob=d=nbodmlheZ<mi(lloy
et al, 1989) and the Navajo AmericanIndians(Hughson et at,1989). TbeZuni havethe highest
rate cf renaldisease of all Indian tribes . over halfof thisrenaldisease is ron-diacenc, presenting
as mesangiopathicglomerulonephritis with asymptomatichematuriain childhood, followed by
protcinwia at a later age (Hoy et al, 1989). Genetic drift and high leve ls of consanguinity may
explain the predisposition observed in this group (Hoy et al,1987).
Tbereare several reportsofglomerulonepbritisoccurring in identical twins(Royet at. 1971; Bader
eral,1974; Kikuta et al, 1983; Charasse etal, 1993). Baderetal(l974)reportedidenticaltwins
"""had_clUDcoI"""""and"""'hisoolog;caI fin<tingoof__plMding
support forgcoetics andthe imponanoeof enviromnentaI influeocc in the oc:pbroti<: syndrome.
Ca ution sbluJdbeusedwheninta'p'Cting twinsrudies. Oftensuch case rqxxts have little tr'I(J(C
thancuriosityval~. Structurtdsn.tiesoftwin pairs. with knoYm ascatainmc:nt,are necessary10
begin to accurately infer genetic andenvironmental influenceson liabi lity .
A study on the preva lence of primary glomerulonephritis in relatives of patients with
g1omena1onepbritisinBrittany, Fran:e(Charasseetal, 1993},found7 families,of480, with at least
2otherfamilymembmwithbicpsy-provengiomerulonepbritis.including4familialcasesoflgA.
nephropalhy. I familialcaseofmembralll>prolife:rative glomerulonephritis.I of membranous
nephroptthyand I focaJsegmentalglomeru.losderosispc:digree.Tbc:sefamlIialcases included _
ratherandchild.sibling pUts IUdapairof monozygotictwins.Therc:suJts led the researchers10
susp::a sharedeoviromncnr:aJ andgmebc: tilctor5in the cccerecce of (rimary gIomcruIooqmtis
InvesngatOrS inGennany~ surpised at the propxtion ofglomerulonephritis patiemswhose
disease wasfamilial; ten percent of their patients hadanother family mem ber diagnosed with
gJomerulonePuitis(R.an'lb;mo;ekdal,1987). \oVbe:nthesefiunilies~invcstigatcdclinicaIJy, 10%
of the patient'srelatives werediagnosedwith glomerulonephritis. While themajority (:50%) of
these relatives had glomerulonephritis of Alport's type (which is a single-gene condition), a
subsantial propo<tion hadliuniHalgiomerul~of"""",,,porttypc. T"""'Y_""",",of
the relatives had atypical glomerulo nephritis forms . 18% IgA nephropathy and 1.9% focal
segmental glomerulosclerosi s.
t.J.t.l1gA aepbro pa tby
Therearesuggestionsofgeuetic wriation inrisJcongA DeJitrorethy. Familialclustering ofIgA
nephrop1thyhas been described (Julian et a l,1985~ Levy et aI. 1987; O'Connell et aI. 1987~
RambauscketaI.1987~Chara:sseetaI.I993). Levyidcntified22 familic:swithmultipleaffected
inslancc:sofIgAnepbrope1hy. A bighp-ewlcnccisobse:rved inJapm(Hikietal, 1990), Australia
(O'Connelletal, 1987) andFrance(8crthoux et al, 1988) andcertain regionsof the US. but not
in othercountriessuch as England(Sissonetat. ICJ75). TheincidenceoflgA.nepbropBthy is mu::h
lower in blacks(Jenette et ai, 1985) , Asians and American lndians (Jacobsonet at. 1995) than
in whites. Abnonnalities ongA immuneresponse inapparemtybca1tby ~larivesofplticnlS with
19Anephropathy have been described (Egiclo et al, 1987). A Ja panese studyon rela tives of
pesoeswith (gA nephritisfound theriskof firsl degreerelatives dcYck>ping protcinwia was 10
times higher thantheoverall population risk (No m ura et at. (993 ).
Dataon associationsbetween human lcucoC)itc antigen(HI.A)markerallelesand IgAnephropa1hy
are variedand contradictory. Earlystudies reportedHLA identical brothersaffectedwith 19A
nephropathy(Tolkoff-Rubin etal , 1 978~ Sabatieret el,1979; Katzet al, 1980, Nomoto et al,
1 984~ An associationofHLA-B27 and HLA-DRI wasfound in Africanandwhite Americans
with IgA induced giomerul onephritis(Freedman et at. 1994A). AHLA -B27 associatioo has also
\0
been foundinAustmlianAboriginals (O'Connell et al, 1987).ffiA 835 wasfoundto be relatively
frequent in a largepopulationofFrench patients with IgA nephroptthY,andappearsto be a risk
factorfor progressionto ESRD(Berthoux et al, 1988). Several studieshave reported an l-U..A-
DR4associationinlapanese IgApatientswith impairedrenalfunction(Kashiwabaraet al, 1982;
Naitoetal, 1987;Hiki etall99u)whileabighfit:quencyofHLA-DRI 2 is found in Chinese IgA
patients (Li et al, 1992~ Notall studies, however. have fotmdHLAassociations (Rashid et el,
1983; Julian et al, 1985).
IJ.I.J Idiopathic Cocalsegmental sclerosis aad mesangial sclerosis
ForidiOfBlbic focalsegmental sclerosis(FS) andmesangialsclerosis(MS)ageneticallydetermined
susceptibility issuggestedby the occurrence of the disease in siblings.andthrough successive
generations(Agaretal , [980; Walker et al, 1982; Kikutaet al, 1983; Tejami. 1983; Tranninet
al, 1983; McCurdy et aI, 1987). Two of27 patients with FS in Walker's (1982 ) study were
sstes whosemotherdicdofrenal tailureata youngagc. Thefiltherofanotherofthege 27 patients
diedof renalfailureat a youngage. Ina thiId family,4 memberswithFSRD hadrenal. failuredue
to FS (Walker et aI, 1982), A case report of one famil y found threeout of four siblings had
nephroticsyndromewithdiffusemesangial sclerosis. two ofwhom werea pairof identical twins
(Kikulaetal,198 3).
Thereare reports thatffiA·DR4 andffi..A·A28 are associatedwithidiopathicFS (Glicldichet
II
al, 1988A). TheHlA BW53antigen allelewas foundto beincreased. in lrequerK:y amonga group
ofFS patients whoserenalfailurewasthe resultof drug abuse (HaskeUet el,1988). The sample
sizesinthesestudies ~smallandtheyrequireconfinnationwithmoreextensivedata. In amon:
recent analysisnoHLA associationwasobservedina group ofFs ESRDpatients(Freedman et
at.1994A). Astrongerindicationfora geneticpredisposition,possiblyHLA.linked. comes from
transplant studies oflndividuals with FS. Thereis a higher recurrence rate of focalsclerosis in
transplanredkidneysofFs peneets iftbedonated kidneycomesfromarelative compared to if the
transplantcomesfromacadaverickidney(Zimmerman, 1979). Anwnberofdiseasesassociated
with FSor f'S..llkelesions.such as Alport's syndrome.,diabetes and. essential hypertension, are
knownto bearan inheritedor familial trait(Weeningct el, 1986). Srcdies in the 1abomtoJy rat have
sbownthatFS-likelesionsdevclopspontaneouslywithaging inmostleboraroryratstrains,although
a considerablevariabilityintheseverity of thelesionsandthe accomp1llYing clinicalsymptoms is
found among differen t strains (Weening et al, 1986). A gene on chromosome I has been
suggested as causi ng glomerulosclerosis in the fawn hooded rat (Brown et al, 1994).
1.3.1.4 Membrano us and acu te po1Jbtre ptococcal glomerul oneph ritis
There have beenreportsof membranousnephropathy(MN) occurring ina pairof monozygotic
twins and five pairsofbrothers(Satoetal., 1987). Multipleaffectedsiblingshasbecnreported in
ninefamilieswith membraoo-polifera:tiveg10mcruJ0nephriti (Belly et al,1981;Sturchfieldet at.
1986). In one oftbese families membrano-prcbferanve glomerulonephritis occurred in four
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brothers and a father. Analysesin severaldifferemethnic groups revealassociationsbetween
membranousMN and lU.A phenotypes, includingHLADRJ (Klouda et al, 1979; Welch et al,
1986; Huang, 1989; Oarketal.., 1993; Freedmanetal, 1994B),ffi.ADRBI (Mulleretal. I99S) ,
HLADRS(Freedmanet al, 1994B)and HLADR2in the Japanese (Naito et at,1987; Ogahara
et at.(992) . Sackset at(1987) haveidentified Wlique restrictionenzymecleavagesites in ffi.A
DR3·positive Ewopeans with mesangia.lglomerulonephritis.proving thepresence of disease--
associated DNA polymorphism. There have been suggestions that the epidemic of
poststreptococca.l glomerulonephritis observed in some families corresponds to recessive
inheritance (Rcdriguez-Iturbe, 19 84).
1.3.1.5 Hypertemive reoal disease
There is evidence ora familial risk for hypertensive renal failure . The risk ofESRD from
hypertensionwas foundto be t8 timeshigher inblacksthan whites inan earlystudy(Nostrand et
al, 1982). Even when black andwhite patients are matched for prevalence. severity and age of
onset ofbypertensionand diabetes, the relativerisksccmpered to whites are still~ timesgreater
for blacks (Whittle et al, 1991; Powc et at.1995). The occurrence of renal failure in a c lose
relativewasfoundto increase AfricanAmericans'riskofESRD (Ferguson et al.1988~ Fre.edman
eta! (1993B) fuund1halbypenensive ESRD ""-1eJlO'1"d bavingonothecfilmiIy memberwith
ESRDmoreoftenthanotherESRDetiologies;fonypen::entofbypertensive patientsbada family
historyofrenalfailure. Theangiotensin- l-convertingenzymebasbeensuggestedroincreasethe
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riskof renalarterystenosis (Missouris et at.1996). In addition . the HI.A DRJ allele has been
found to be increased among black hypertensive ESRD patients (Freedman et aI, 1991).
1.3.1.6 Diabeti c:: nephropathy
Diabetic nephropathy occurs in35-40% oftypc I diabetics with disease of40 yearsduration or
greater. Increasingblood glucose levels, duration of diabetes andpresence of hypertension are
known risk factorsforprogression of diabetic nephropathy (Kra lewski et ai, 1985). This leaves
much of an individual's risk. unexplained.
Racial.differences in theprcva.Ience ofdiabetic reraldisease implicategeneticfactors in risk. The
AfricanAmerican raceappearstobethemostimportantriskfactorinpredictinganindividual's risk
fordevelopingsubsequentdiabeticnepbroJ:aJhy. thiscondition is3-7times morefrequent in black
patients compared to white patients (Nostrand et al, 1982). Mexican Americans and Nativ e
Americansalso haveadisproportionately higherincidence ofrenal failure fromdiabeteswhen
co mpared to other racial gro ups (Pugh et al, 1988).
Severalstudies havesought to determine whether the excess diabetic ESRDcouldbeexplained
bythe disproportionateraresofdiabetes andhypertension,andlowereconomic statusof specific
ethnic groups. Tierney et al (1985) found, after controlling statistically for the prevalence of
diabetes. glucose levels, hypertension, heartfailw-e andmale sex, all of whichare significantly
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related10nephropathy, thattheIikelihoodofincreascdserumcreatinine levelswas92% higher in
blackscompared to whites . Blackdiabetics are at a higher risk for diabetic ESRDthanwhites .
particularlysubjectswith non-insuJin-dcpendentdiabetes (NIDDM), evenwbenaccessto health
carc ,socio-economicstatus.pn:valenceofdiabetesandhypertensionarecontrolledfor(Brancati
et at.1992). As well, a 2.6 fold higher risk for overt proteinuria hasbeen found in diabetic
MexicanAmericanscomparedto diabeticoon-HispIInic whiteswhentheeffectsofglycemiclevel,
blood pressure. smoking and insulin arc controlled (Haffner et at. 1989).
Several researchers bave repo rted that the renal status ofdiabetic siblings best predicts the
developmentofnephropathy indiabetic patients(Seaq uist et el, 1989;Quinn et al, 1992; Berch-
Johnscu et al, 1992). In insulin-dependentdiabetes. 83% ofdiabetic siblings of probands with
diabetic nephropathy have evidence of diabetic nephropathy. compared with 17'%ofdiabetic
siblings of probandswithout nephropathy (Seaquist et ai, 1989). Familial clusteringof diabeti c
nephroplthyhasbeen observedinPima IndianswithN1DDMleadinginvestigarors to suspect that
asuscepC:ibility todevelopdiabeticoephroplthyexists indcp:ndentIyof thesuscept1bili1ytodevelop
NIDDM(pettin et al, 1990). Pettitt'sstudy(1990)of499 diabetic family membersof a group of
NIDDM patients foundthatprotcinuriaoccurrcdin 45.9% ofthediabetic offsplng ifboth parents
had diabetic renal disease . When diabetic renal disease was present in only one parent the
~enceofproteinuriaindiabeticoffispringwas229"/o.and 14.3% ifneitherpuent baddiabc:tic
renaldisease. Ina studyby Freedman et at(l 995A). 37% ofNIDDM ESRDpatientsreponed
is
havingafirst..seaniorthird~ relativewith rmal finliRoompucdto 7% of diabetic comrols
withoutESRD . It basbeenbypothesised that susceptibility to diabetic llCpbropathy may be
inhontod~of_"""""" _"""_"""'~willdo",onIy
in the presenceofdiabetd (Bennett eta!. 1971; Bamettetal, 1986; Seaquist. 1989; Pettitt et al
1990).
Agenetic predispositionlO hypcrtens ion or cardiovasculatdamagehas beens uggestedas the risk
factor for thedevelopment ofnephropatby in diabetes. An increased risk ofrenal d isease in
diabetic personswascoserved if hypettensionorcan:fioolasculadisc:asc waspresent in the parents
(Viberti et al, 1981; KroIewskiet al, 1988; Earleet al, 1992; Stephensonet all99S). Earleer
~(I992)oudicd61~""""_"""""",","""61~potiems
wilhoul""""""'"' ''''''_'''''' 4O% ofthcpouemsof_oq>hropoIhy ........__
canliovascu1acdiscase compuedlO22%ofparents ofdiabctic ptbcnuwitbout nephropathy, this
difI'=noebdng.~ F",,",,_frr1hebjpolhesis"""~"bypenemion
may play an important role in the suscepbbiIityto~ diseasecomes fromstudiesof red blood
cell sodium--lithiumCOWlter1ranSpOrtactivity(Krolewskietai. 1988; Manglierat, 1988; Joneset
el, 1990; Walker et el,1990);~ is increased activity in diabetic patients with nephropa thy
co mpared to diabeti c patients with out nephropathy.
StldicsooACEgcnepolymorphismanddiabeticnephropathygivecontnldictDfyresults. Barnas
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e aI (1m) found that the [).all ele for the geoecncodi og the ACE inhibitoBOCCllrmI more
fn:queudyin patients withdiabetic nephropathy compared to control s. Not all studies have
confumcd this findin g (Bi la ee aI. (99 5).
1.3.1.7 Vt:5icouret eral reD...
PrimaryVesiCOW'etenll. refluxoccursinfrequently amongtheblack populationsuggesting that
genetic factors play an important role in thisco nditio n (Burger , 1972). Since the recordingof
vesicouretera.l refluxin identical twinsby Stephens el al ( 1955) therehave been a numberofother
su:h obseTvarions(Mebustetal. 1972; Hampel et al, 1975; Kicret aI. 1983; Sirotael al, 1986)
anda reportofaffeeu:d triplets(Hayden et al,1984~ Theoccurrmce of vesicoureteral reflux in
members of the same family and in di fferent generations hasalso beendocumented in sevaa.I
studies (Bn::denet el, 1975 ;~n. 1976;DeVargasct '" 1978; Jerlcins et el, 1982; Baily et
a1.1984 ; Aggarwal et aI.1989; Nee . 1992; Peeden et al, 1992 ). These reports establish the
presc:nccof refluxasa potential familial or bereditary problem. The me ohesic:oureteral reflux
in normal bealthy childrm isestimated as being 0.4 and 1.8% (Bai ly, 1979). A much high«
prevalence (1 1-S2% ) in siblingsofpatients bas beenfound{Bredinet a l,197 5; Dwosk:in. 1976;
DeVargas et a!, 197 8; Jerkinset aI. 1982; Baily et al, 1984; Aggarwal et al, 1989; Noe . 1992;
Pecdc:net al, 1992). A prospectivestudyby Sirota et aI(1986)on a highly selected groupof 16
oftbese familiesfound asiblingrateof 1000/0. butsixteen fimillieswereselected for investigation
because. in each. two familymembershadp-eviouslybeer!identifiedwith refluxand82% of the
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siblings were sympt omatic.
Wbilethepanr:ms of~~in1hesefamilies~aninherib::dbasisfor rdJUltin
aproportiooofpaticnts, oouniforminheritancepattc:misobserved. Millerctal (lm)and~
eta!( I97S)pmposed an autosomal dominantmode of inheritancewith variable expn:ssion of the
geneand incompletepenetrance. X-linked inheritance basalsobeensuggested (Middletonet at.
1975;Tobekineret, 1964). Segregationanalysisofdatafrom88familiesmoststronglysupports
a single major locus modeofinheritance (Chapman eral,1985); theI~ being dominant. with
45% ofgene carriersaffected. Theoccurrenceof refluxamong SIb ling! has also beenexplained
in terms of muhifactorial · polygenic modeofinheritaoce. Age-felated onset and lntenction of
bcm1itaryfactorswith errvironmental factorssuchas infectiooprovidearea.sonabl.e expla:nal:ioo
fu<lhewriability in""""'r.typoand _ """""oqx><1<dunoog filmilies(Burg<%. I'172;
DeV argas et al, 1978; Jerki ns et ai, 1982).
1.3.1.8 Other reea l diH:au: types
In patientswith urolithiasis, a positive family historyis extremely common (McGeown. 1960;
Resnick et aI, 1968; Churchillct el, 1980; Ljunghallet ai, 1985). Risk of developing renalcell
carcinomahasbeenfoundto beinacased in raticmswi1h• familyhistoryof renalcellcancer(Eng
et ai, 1993).Molecularstudies have implicated a specific geneon chromosome 13(Stein et aJ..
1995).
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Chapter 2
RESEARCH OBJECOVES
A prerequisiteto measwing familialrisk of inheritedrenal diseases is preci se estimates of the
prevalenceof these diseases. The prevalenceof inherited renaldisease willbeunderestimated if
epidemiological investigation offamilies is not conducted.
U Prima ry B e;wl rr;b ObiWYeI
To detenninethe frequencyofES RD due to diseases witha known Mendelian pattern of
inheritance in Ne wfoundland.
2. To dctenninc:whether relatives ofESRD patients have a higher risk of ESRD . than
relatives of co ntro l subjects.
3. To determinewhether therate of renalfailurein relatives ofESRD pttients, as confirmed
by CO RR registra tion, is higher than that in the general population.
4. To identify fiuni.l.ies withmorethanonc:affectedmember, withoutasinglo-genedisease.for
further collaborative study .
5. Todescnbe the naturalhistoryofdiseases with siegie-geae inheritance identified in the
I'
Newfow1d1ardpopu1arion. with particularfOcus on DeW data associatedwith Bardel-Biedl
Syndrome.
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.LJ. ImpmYemeDh iu research desigg romp'red to earlier !'Itudia
Thiscase-ccccot studyis the largest: to date to examine the influenc:e offiunilial factors on therisk
ofdevelopingESRD. Furthermore,it focusesona populationwhich arisesfroma homogenous
genetic population. Drawing probandand control subjects from a large pcpuation-based case
controlstudy with systematic aso:rtainment ofall cases and controls. includingdeceasedp!1ierns.
repeseeaanim~ over previousfamilystUdies, whichascer1aincd theirstudy population
froma single hospitalsetting over a shortperiodof time(Steenland et el, 1990; Freedmaner al,
1993B;Spnryetal.I995). Thisstudysougbtcomplereascertainmentovera6yearperiod(1987-
1993). Over1,000 probandsand controls . fromthree health C8Ie facilitieswhichtogether treat
all ESRD patientsin Newfoundland and Labrador, were identified. This avoids possible bias
arisingfium. whateverselectionfactors leadindividuaIs to utilizea particulart:reaJ.meIltcenre. The
patients represent different geographic. educational and social backgrounds.
SeveralfeaturesofNewfoWK1land make itananractive placeto do genetic research. Theoutport
society,withitstendency to~ families. geographic remoteness. relativeimmobilityandstrength
offilmilytiesprovideforinvestigationofrdativelylarge.stablefamiliesofsevcralgenerations.The
wrifonnlivingcoOOitionsintbeseisolatedcommunitiesmayfacilitatestudyingthen:larivecff~of
geneticvariation versusenvironmental differences. Opportunities for foundereffectand re1ativdy
highlevelsofconsanguinityincreasethelikelihoodofobservingrareorpreviouslyunn:cognised
dominant andrecessiveconditions. Cooseql.ettly, it hasbeenJ'OSSIble Cormany genetic disorders
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to be investigated in Newfo undland and I...abrador.
Prev10usstudies elsewbeee did DOC ascertain ~cnce of ESRDamongrdatiw:s of diffemn
gencrarions(Steenland elal . 1990; Fn:c:dmanct al. l993B~ SJnydat. 1995). Tbeirrisk ratios
were basedon the proportion ofindex cases thatbada positive family history of renal failure
withoutanyconsidc:ral:ion of family size. Thepresent studycalcu1aledrisk ratiosbasedon the
proportionof relatives having renalfailure. as well as on the proportion of indexcases with a
positive 6uniIyhistory. Riskratiosbasedooproportionofindc'tC8SCS with. positivefamilyhisuxy
can be influencedby family size. Theincrease in numbers in larger families will increase the
proband's chances of having a fami ly member who basrenal failure . Risk ratios based on
proportion of index cases who have a positive family bistofy will th us overestimate risk.
CaJcu1atimofrisk:ratiosbasedon pnportion of rda!M:s~ for al3mily bisroryofn:nal&ilun::
pn;Mdcsamoreaccurate assessmentofrisk. TIW; caJcu1aJed riskratiois lessinfJ.~byfiunily
Collectionoffamilydata for both spousesandcontrols was basedon several.interviews with
5e"m'8lfamilymcmbers;~ investigatorsappeartohavegathcre;l information during asinglc
interview with only one fami ly member.
Theusc of spouses as a co ntro l group represen ts an additional improvement over previous
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investigations by reducingm::allbiasand allowingfewerdifl'erenccs in envirommenta.I exposures
(Coughlin. 1990; King, 1992; Drews.1993; wtckramaratare, 1995). Previous investigators
employedage andsex matchedcontrols from the generalpopulationor a hospitalpopulation. It
is believedthat use of a randomsample from the populationprovidesless statisticalpower to
detectthe presenceoffiunilial aggregationthanthose performedwith acontrol groupef relatives
ofprobandswithoutthediseaseofinterest(Wicknunaratare., 1995). Finally,thisstudyhada low
refusal rate for both the proband and control groups.
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Chapter 3
STUDY DESIG N
J.l _
Two epidemiological approachesused to detennine if familial aggrega tion occurs are: a ) to
c:omparcdiseasefrequencyin relativesofcasesversuscontrols,and b)to comparethe mquency
in relative s of probands to the rate in the general pcputenco (Khoury et al, 1986).
To detmnine if a familial clusteringofmW failure was JRSCTIlin thisstudy population, a case-
control srudy wasemployed. In this type of obscrnttional study persons with a given disease
(~) and persons withoul thegiven disease (controls) are se lect ed and compared fo r a
~cullU"risk factor( Sackett, 1 99 1 ~ In theJRSC1ll study, prob&nds~ individualswOO had
ESRD. and the controls werethe proband's spouses who werefrom, in general the same
environment andv.wI d beexpected to beaware oCthe oatUre and significance ofESRD. To
determine whetherfamilyhistoryplayed a mle in the developmc:ut ofESRD. the incidence of
ESRD in relati ves of probands and contro ls was compared.
The~enccofrenalfailurcintheproband'sn::lativeswasalsocompat\'dtotbatintbcgeneral
population; that rate beingthc~ rate reported tothc DlItionaI registryfor ESRDthenlpy
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(CORR; AttemplSw=madetoveri1Y'"l"""byflomilyIDfonnamsof",,,,",,,,beiDgUf,,,,",,
with ESRDafter 1981with CORR.
U Rtoll hi., l ad oCbrr d",dnntaW o(cuc:rogttol l tu dia
Whilethecase-control studiesgeocmIlyaRrdativdy inc:xpm>ivc.canbec:ompk;ted ina rdatiYeIy
shortpc:riodoftimeardaIJow a description ofincidenoe ofdisease.theyaresuscepbble to~
soun::c:sofbias(Sackett. 1979~ Amajorthn:atlDthcvalidityofcase-controlstudiesis~lbias,.
whicboccurswhen"essociarionseredisrmedorcreatedbeceasecaseinfonnantsreJXll1differently
fromcontrols"(Drews et al, 1993). D;fferentialrecall will lead to spuriouspositiveassociations
orbiasawayfromlhenuJl(Cope landetaL. 1m; Berrcnet et, 1977; Raphael.1987; Drews er
aI.1990; The=ill ofa""" &miIybislD<yooulddqxnd marl«dIyon_!he infunnant
ls. caseorrontrol. Sackea:(I979) refersIOthistypeofreca.l1 biasasfamilyinfonnatioobiasand
theeffcctupoo the rdativeoddsmay beprofouod. Forinsfanoc. in. studyon familial clustering
ofrbCl.maloidarthritisthe~ofapositM:histlxyofrheumaroidanhritis ina parmt hasbecn
shown to bereported moreoftenbyanoffspringaffected with rbewnatoidarthritis than a non-
affectedoffspring(Sackett. 1979~ Pastexposureto possibleriskfactorsmaybemore vividand
mcaningful toaffected persees because oftheirf.uniliarity with thediseaseand because of repeated
interviewingbynursesandphysiciansfortheirfiunilybistory(Coughlin, 1990).Probandsmayhave
previously questionedother relativesforinformationon the disease whentheythemselves became
ill . Conversely, controls are less sensitised thereby decreasing the chances ofrecall.
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Otherfactorswtrichmaycoorribub:todiffererttialrecallincludemotivalionandmeaningfulness. The
motivation to participate and answer correctly may begrea ter for patients than for controls
(Raphael.1987). Theresult willbean intlationof riskestimates. Otherpotentialproblemsof
case-comrolstudiesarefaultyinterpretationofthequestionbytheinterviewers(Coughlin, 1990 )
or extensive probing amongst the probandsduring the interview for the desired answer . An
additional source of error is pedigree error. This may be due to unknownnon-paternity,
unreportedillegitimacy8Id~ons. PedigreeerrorsusualIyresuItinanurdertstimateoffamilial
riskwhen genesare involvedbecause theysubstitute random individualsforrelatedones (weis,
t982). Case-control studiesalso make theimplicitassumptionthat as a rule, risk figuresare
constant in time and space. Considering the environmental changes this assumption is not
necessarily true (Vogel , 1979) .
Recallbiascanbe minimizedbyusingcontrolswhoarelikelyto baveconsideredthedisease to the
same extent as probands(Coughlin. 1990;Drewsetel. 1993). Wicknunatrie etal(l995) found
that usingrandomlyselectedcontrolwill belessefficient,statistically, thanusinga controlgroupof
relatives without the disease. The use of spousalcontrol subjects offers several potential
advantages. includinga lower tendencyto recallbias andfewerdifferencesin environmental
exposuresbetween JXObands and controls. Spouses of patientswith renaltailurearelikely to have
considereda givenfamilydisease tothe sameextent as probandsand are thereforeare less prone
to recallIH"("""","",,,, m.."l thentbe.".,.,..J population(Couglilin.1990;King, 1992;o..ws.
2.
1993). Se\aaI inYcstigators havealso foundthatdiffcrmtial m:aIl eces not alwaysbias estiJnaIes
of associationsaway from the null e\'eII whenprobandsare more likely to accuratel y report
information thancontrols (Zierler et el, 1985; Mackenzie et al, 1989; Drews er al, 1990).
NewfoundJand's.scuingandhistory allowforan ideallocationforgeneticinvestigationdue to the
isolation and inunobiIity of it's communities. Thesefeatures also may predispose to genetic
relatedness~ spouses. Thismighttendtodilttte anyassociatioo betweenfiuniJyhistory and
renal disease due to polygenic inheritance.
Despitethe limitations ofca.sc-<:ontrol familystudies tbesestudiesprovideaneconomicpractical
way10initiallyexaminefamilyriskforcc:mmon. diseases. Thisswdy anemprs to renee recaUbias
through:a)thc selection ofa controlgroup which is similar mage andenvironment and has had
cxperieJx:c with renaldisease andb) byrq:w:atedly intervlewing'4rious family membcn.. The
primaryoutcome ofintcn::st in thisstudy- ESRD· is a majorevent and likely 10 bererrembeed,
particularly if dial ysis is a consequence of the disease.
27
Chapter 4
METIIODOLOGY
.f..l Stu dy oop ula tio g
4.1.1 As«rtaill meDI or proNods
The study population wasascertained usingEndstage RenalDisease(ESRD) registries and the
Cano<lianO<ganR<pl=rnentReg;my(CORR)mthelhree Newfoundland""""tab whcreESRD
tn:atment is available. Both ESRD data baseswere used to obtain a complete list as it was
observed that theRwassome degree of underreporting (29.6%) to the CORR registry . The
HealthScic:ncesCenm(HSC) and SalvariooAnnyGnlce Gc:neral Hospital{SAGGI-Oservethe
eastern putoftbeisland, includingthe Aw.lon Peninsula. Westem Memorial Regional Hospital
(WMRH) sen'CSthe popufatiOll in the MStJ:m (Bltoftbe~ Thc:se~record all rcw
casesot'ESRD.demogn.pfricdata,diabeticarxihypertensionhistory , renaldiagoosis.and dateof
first ESRD therapytrea tment
Eligiblecases weredefinedas all adult male andfemale patients who were receiving ESRD
-(1nU>SpIonmtion,hemo<ti~ ... periton<aIdiaIysis)m 1987 ond ony """"""who bogan
therapybetween1987 and 1993. inclusive. Verification ofadiagnasisofESRD was madeclear
based on medical records . Probands bad to be at least 17 yearsof age at the time of the
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iIM:stigation to beincl1dod in thestudy. PatienIs \\00 diedduringdtisinteMlI wereitdudc:d The
principalexclusioncriteriawasrenaJfailuretha1:wasconsideredto be potentially reversible
(D"'15O). Thisjudgementwasmadebyaclinicalnephrologistwhowas~withpertinent
clinical dalaandwas blinded to pdicm identity andoutcome . Thedecision wasbased 00 the
presence and degn:eof~g chronic renaJ impainnent andthenature and severityoftbe
process leadin g to the needfor dialysis.
Thisstudypopulationrepresentsthe entireadult Newfoundlandand L.abrador population with
ESRDduring thisperiod Bccauscnotail ESRD patients wereregistcm1 with CORR(Tabl e I)
"""" WMRH"""ems may """ beenmissedbecause theycere_ mainly_ <:oRR
registries.Thisnumbershouldbe relarivelysmall, however.as manyof the WMRHpaticn tsalso
received treatment at the HSC AlsomisscdlR personswho bad~ to renalfuilurebut
refcsedoewee tu:rned downanyformofESRD~ bc:cause thesepatients \1IOlId ooc: hiM:
beenregistered with hospital or CORR registries, It is unknown what this number is.
4.1.2 ClassifiatioDof Renal Disease ia the Proband
The medicalrecordsof all eligiblepatients werereviewed,includingrecordsfor all hospital
admissionsupuntil thediagnosisofESRD. Pertinent informationfromclinicrecords. consultation
letters from nepbrologists and corresponding letters from physicians were reviewed. If the
diagnosiswasnotspecifiedatthetimcESRDtberapywasstarted,subsoqucntmedic:aJadmission
2.
reccrdsweereviesedlnfoonationobtainedoneach peneet included: dischargesummary, bistoty
of hypertension(ifprescnt, length and any medication), historyof diabetes mellitus(ifpresent,
dw'lltion,typeofdiabetes.prcscnceofn:tinopathyoranyotherdiabeticcomplicatiorn;),historyof
tuberculosis,historyof renalstones orurinarytract infections, timdiagnosisof renaldisease"age
at first ESRD therapy, discharge reports , renal ultrasound reports . biopsy reports, voiding
cystogram. renogram.blood andurinetests, autopsy reportsandfamilyhistory. Anyadditional
medical data relevant to underlying rena l disease wasalso reviewed
The informationgatheredwasreviewed byasingleclinical nephrologist,bIindcdasto theidentity
of the pecen, and eachprobandwas allocatedintoone of the followingnine: diagnostic categories
based on defined clinical crit eria:
I) Glomeulooepbritis- renalbiopsyprovenor winaryproteinexcretionofmorethan 3g124hr
andpresenceof redblood cell (ROC) casts or 2+ hematuriaor greater . Patientswith bilateral.
smooth, small kidneys and proteinuria are not allocated to this group nor are patients with
glomerulonephritissecondary to other causes such as lupus, polyaneritisnodosa,Goodpasture
syndrome. HenochSchonleinpurpura.Aipott's syndrome . Themajor formsof glomerulonephritis
includedare 19Anephritis, post-infective. membnmous.,membrano-proliferative anddiffuse
proliferative (including crescentic) glomerulonephritis.
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2) Diabetes Mellitus-
Type [ - developed diabetes before the age of35. duration of to years or more
and remaining on insulin therapysincethe diagnosis of diabetes ; presence of
retinopathy.
Type 0 - receivingor:al agents as therapy, or developed diabetes aftertbe age of
35, withduration of 10 years or more. Patients with a concomitant history of
hypertension were retained in thiscategory.
3) lntelstitialnephritis-urinaryproteinexcretionof~2gfl4hr in thepresenceof a risk factor
for interstitialdisease ; e.g renaltuberculosis. nephrolithiasis (bilateral renalstones sufficiently
exrensivetocauserenalfailure).vesico-meteralre8uxnephropathy,pyelonephritisintheabsence
ofobstruction or nephrolithiasis .
4) Hypertensivenephrosclcrosis-essentialhypertension forat least Inveers, urinaJyprotein
excretion of:S 2w'24hrand either hypertensive retinaldisease or electrocardiograph evidence of
leftventricularhypertrophy. Threeprobandswith extensiveva.sculardiseaseasprirnarycauseof
renal failurewereallocatedto thisgroupbecause theyhadpreexisting hyperrension. These patients
hadgrea:terthan600AJstenosis inbothmain renalarteries. ortbe single renalarteryofa patientwith
a single functioning kidney.
3\
5) MultipleCauses •presenceof~ or more factorsreasonably inferred as leadingto ESRD;e.g.
uninephrectomy andsome other disease.
6) Other - includes patients with diverse etiologies. This category includes: a) obstruction; b)
autoimnllmedisease;c)~c and;d) othe:reauses. Obstructive uropl1hyincludescongenital
malformations. such as posteriorurethralvalves.pelvic-ureteric obstruction. spina bifida or
neurogenic bladder,andacquiredobstruction. Scleroderma, lupus , vasculitis , polyarteritis.
cyroglobulinemiaandpulmonaryrenaldiseases. includingGoodpasturesyndromeandWegener
syndrome.an::aUocatedasautoimmunediseases. falrogeniccauscs forrenal failureincludeESRD
secondary to radiation damage, anaIegisic abuse, cho lesterol embolism and antibiotic
nephrotoxicity. Otherless frequent causes ofESRD include hemolytic uremic syndrome,
sarcoidosis and amyloidosis.
7) PolycysticKidneyDisease- autosomal dominant polycystickidneydisease as confirmedby
imaging and appropriate family history.
8) OtherGeneticDiseases-patientswith recognisedsinglegeneconditions includingX-linked
dominantandotherfonnsofAlport'ssyndrome;aurosomalrecessiveBardet-Biedlsyndrome.2,8
dihydroxyadeninesyndrome,hypcroxaluria,Carolisyndrome;andautosomaldominantChartot-
Marie Tooth disease.
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9) Unknown- absence of clinicalevidence in medicalrecordssufficient to ascnbe an etiology.
The majorityof patientsin this category firstpresented to a physicianat thepoint where renal
diseasehadalreadyprogressed to the point ofureversible severerenalfailure andelucidationof
the original renal pathology was not possible.
Theattribution ofa primalydiagnosisforESRDisquitediflicuitandsubjectto opinion. Thebroad
nawreoftbeclassificationmaylumpdisoIderswithdifferentgeneticpredispositions. Consequently
the heterogenousnature ofthedisorders ineachclassificationgroupmayconfoundidentification
of genetic risk. A substantial ly deeper study would be necessary to overcome this problem .
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~ <;norm! oopgl,tiog
Thecboiceofanappropriatecomparisonis essenlialto ensuringvalid results in case-control studies
(Drews et aI, 1993). An associationis necessarily more convincingif it is found whendifferent
types of contro l groupsare used(Kelsey et al, 1986). The present study uti lizes two control
groupswith which to compare ESRD frequencyin patients' families. It compares the prevalence
rateofrenalfailureintherelativesof~withtheprevaleDCeratcofrenaIfailureinrelativcs
of the probands'spouses . It also compares the prevalence of renal failure among probands'
relativeswith thatin the generalpopulation,asdocl.anented for thepovince in the Canadian Organ
Replacement Registry (CORR).
4.2.1 Prima ry control group - As«rtainmcnt of spousal families
Potentially, spouses can make up a population similar in age and environment to probands.
Spousesshare the same geographicand familyenvironmentas probands. but are 1101: usuallyclose
biologicalrelatives.A findingof increased renaldisease frequencyin biologicalrelativesof cases
comparedto biologicalrelativesofspousesarguesfor genetic Factors in liability. Useof spousal
controlsshouldreduce recallbias. Whilethespouse isnot directlyaffectedwith renal failureand
may not beas awareofa family history ofrena1 disease ccmperedtc the proband.the spouse 's
familiaritywith ESRD anditsseveritymay make spousalcontrolsmore likely to take note and
remember relatives who have hada history of renal complications. especially renal failure ,
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c:ompan:dtomcmbcrsoftbe gmeraI population. wbc ere much lesslikely to havebad ex.posl.R
to renal disease, Spouses can also be expected to be motivated.and cooperative in their
participation in a research study .
For~without. spouse. a spouseofa sibling wbo gave infonnarionon the pubands family
history wasused. Theseindividualswereselected in a randomfashionto avoid bias. In a few
cases the control was a random friend of the proband who waswilling to participate.
4.1:.2 Secoodary rootrol group - CORR registry ra te
The Canadian Organ Replacement Register (CORR) is a nationalinformation system on organ
failure whichbegan in 1981. The data base system: wasestablishedin an anempcto registerall
pstientswbocommencedESRDtreannenlsinceit'sinitiation,irrespcctiveofage. DatacoUected
on patients wbobegan tratmen1 piorto 1981 is incomplete. PTescndy, CORR estirnalc:sthat
registered patients comprise94% of alldialysispatientsand75% ofall kidneytransplant patients
(CO RR. 1993). A lower registry rate (70.4%) was noted in this ESRD population. This
discrepancy is most likely the result of incomplete notifi cation ofttle CORR registry regarding
patierrts with ESRDinoneofthc Newfoundland ESRDtreatmentcemres, TheCORR registration
in this centre was50%. In addition, enrollment in CO RR wasincomplete in its initi al years.
Bycomparing theproportions of relativesof probandsandcontrolsregistered wi th CORR , it is
3'
possible 10 dett:nnine lfthe prnaJenceofraJll1 fililure is higher in rdalives ofpobands. The
aJRRn:gistryalso~ddcmUnarionofwbdberlbendeofrmalWllJl: in relalM::sofpobmds
ishigbertban that in the genemIpopulation,asestimatedby CORR.compared to the rareof renal
fiWurein rdatiYes of lXlrltrOIs compared to the gm::raJ pop11ation TheJX'Jl'l!ation p-evaJcnoe rate
is almosteenainlyan underestimate oCtiletrue burdenofESRD due to the pooreraOIlment with
CORR anda failureto registerpatientswho refused. wcretume:ddown by physiciansforESRD
treatme nt or have died prior to treatm ent initiation.
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U. Collrc:tiog QUlg On rdatjyQ
Each proband's family wassent • letter detailing the purpose of tbe snJdy and the information
required (AppoodixA k B, lnfornxd cccseswas-...t from all ..ooy '""jects, on<! tbe
studyp-otocol\WS appuved by the University'sHwnanInvestigationCommiuee. For families
lFCing to participate in the study . pedigreesextending to third degn:erelativeswere obtained
using telephoneor person-to-person interviewsby either a trBincd research nurse or a trained
researchassistant Initialcontactwaswith theproband. lfthe indexcasewas deceased. another
family member (e.g. spouse.. offspring, or SIbling) wascontacted as indicated on the patien t's
medical recordlfthefitstcorrtaeted fiunilymemberoouldnor. povidc all informarion,ooeormorc
additional familymemberswere contacledfollowingpcnni.ssionfrom initial family informant
fnterviewsgcneraJ.Iy lasted less than 30 mintne:s. and the majorityoffamilies wereaxnacted 2-3
timcs forinformation. Intervi~were cooducled between Marcll I. 1993andFebnwy 1.1996.
InformationobtUnc:d on each famil y memberincluded sex, aetuaIor approximatedateofbirth.
historyofhypertension(if~.ageofonsctanduseofmc:dication). historyofdiabetc:smeUitus
(ifpresent, age ofonset andtreatment regime ). historyof knownrenaldisease , including renal
fai lure .
Ifa family member wasreportedas baYing ESRD, infonnatioo on diagnosis. ageofonset for
ESRD.trtatmerthospital andCORR regisuation \WS soogbt Formoslcasc:sthisinformationwas
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notawilable.ltwasinquimfwhelherthc:re1arivewasalMordeccascd;ifdcceased,infonnation
on cause, yearand agea1death wassought. Iftbe yearofdeath \WS unknown. it was ascertained
whetherthe rdatiYehaddied prior to 1980. Whena rdative'scum:m: age or age at death was
unkno wn to familyinfonnants, theirageswereesarcered approximatelyfrom the known~of
siblings inthatgeneratiOfL It was inquimi whetbcrany familymemberswereb1.indandlordcaf
because several geneticdisorders with thesemanifestationshave~ disease as an additional
feature. ItwasinquiredwhetheranyrelativeshadBright'sdiseaseordropsy. Bright'sdiseasewas
a com mon term.used to describe a collection ofndncy diseases characterise d by edema.
HistoricaUy,Bright'sdisc:aseW3SaunifyingtcrmforkidrJ:yliliIure(Pemeger. l99S). Dropsytd'm
to a generalaccwnulationof nuid which may or maynot be relatedto kidney dysfunctionand,
hisIoricalIy, wasmoreoftenused10 descnbe individuals withS¥odlin8 secondary to ethermcdicaJ
conditionsSlrlas heart&iJl.R. lnformationwassoughIon infarI:deatt5,.sIillbUths. half relatMs.
rwinsandOOllSlllgUinlty. The community ofblnh ofbodI~sandspousc's parems wasalso
acquired,
A checklist wasfollowed to ensure consistency in the response(Appendix C).
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Chapter 5
OUTCOME MEASUREMENTS AND ANALYSIS
M Prima ry o"tromc
ThI:pimluy uutwmc ofimcn:stWKSddiD:dasapositive 6mriI.yhb10ry of n:naJfiri.lure lti:iOt.iattld
with dialysis or death in a first. second or third degreerelative of a proband or control. First
degreerelarivesincludestblings.offspringandparents. Seamddegrcerelarivesareaunts,unclcs..
nieces, nephewsandgrandparents. Cousins, great WIeld and awrts.andgreat grandparents are
third degree relatives .
~ Dcfigjtiou ofprj mlrY gutcome in rr "tjyn
A ramily memberwas CODStdemllO bepositivefor ESRD ifbe or she badWldergoncESRD
tteatmeIIt(transplantatioa. bemodiaIysisorperitooea.ldialysis ).regardlc:ssofthc:underl yingcausc
ofESRD« duration of tJ1:atmellt Ingc:nc:ml.rqxx1SofrmaI f4i1l.R inrda!M::s \loC'e nor \Uifi ed
fromtbcfumily__caIr=rds. _-.........examinodro.fumily"""""'"
presentl y receivin g dial ysis therapy at WMKH. HSC , SAGGH, but who were not probands
hecau.<letheyhegan ESRDtherapyafkr 1993.12. Becausethemedical record.s ofaffectedfamily
memberswerenotreviewed, causcsoftheirrenal failureoouldnotbedetemtined. Although no
effort was madeto determine wbctherthe renalfailure was acute or chr onic . tills should DOt
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mfIuence ~risk:c:stimatcs foundforpobandsandcontrolsbecause thedecisiontolabela relative
positive fur renalfitilure. whetheracute or cbronic, wasmade equally between probands and
controlsbya physicianwho wasblinded as to whether the relative wasthat of a probandor
control Tbisy,ooJdalsonot infIuc:ncetbecomparisonratetotbegenera.l population as onlythose
relativeswho~registeredwithCORRYoereusedforthiscomparison.lnformanuwereasked
whetherthey knewthecauseofrenal failure in relatives; inthemajorityofcases thisinformation
was not known.
Thedecision to label a relative as havingdied from renal fai lure was based on accumuJated
evidence from theinteviewes to whether renaJfailure wasdirectly associated with death . While
althoughthismethodis partial to inaccuracies due to the subjective nature of tile decision, the
resolutionwasmadeby asingle nephrologistwhowasblindedas10whelhermeaffectedfamily
mcmbc::rwasa pOOand's or a cootro1's relativetherebyequalizing thebias betweenthetwo groups.
Many of the familymembers whowerereportedto havebadrenalfaihm:: died beforedialysis
became availableand easilyaccessible inNewfoundland. about2S yearsago . Ifa relativewas
reportedto havehadrenalfailureanattemptwasmade10confirmthe reportwith anotherfamily
member. For familymembers whobegan ESRDtreatmentafter 1980confinnarionwassought
usingCORRregistries. However,becauscootall ESRDpatientsareregistered witb CORR,any
familymemberwhorequiredESRDtberapyafter 1981. wbctherregistered with CORRoroot,
wasconsiderMESR~.ifthe informlltionwasconfinnedbyanotherfumi1ymember. Any
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relativewhowasscheduledto commence ESRDtbcrnpybut died. befbrebeginning treatmentwas
consideredpositiveforESRD. Relatives were consideredpositive for ESRD if theircause of
deathwasindicatedas Bright's Disease. AIryavailable infonnation regarding length of renal
disease, symptoms (flank pain,hematuria. edema). treatment. hospitalizations. surgeries and
auropsyrepom ~acquimtand usedin theimerpretaIion. Theactual medicalreoordsoffiunily
memberswerenot reviewed byaninvestigator. instead, familyinformantsprovidedsuchdeta:ils.
Relatives wbodicdwithrenalcellcarcinoma and renal tuben=ulosis vme coesdered to have ESRD
only if they progressed to ESRDtreatme nt.
Tnsome instances, informants recollections of renal failure causing dea th ofa relative were
contradictory . In these instances theoutcome wasclassified as possible renal failure and not
analyzed for riskestimates. Probands had41 relativeswho were labelled as baving possible
ESRD. Ofthese14 werefirstdegrcerc:latives.2 1 weresecond degree relatives and 6 were third
degree relatives. Fifteen relatives of controls were labell ed as poss ibly having renal failure.
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M SgtlttjAIIQ.Iy,j5
~.1 Demograpbic data and measures of risk
Dcmograpbicdatacollectedincludedgender, age of onset forrenalWlurc. Genderdifferences in
ageofonsetofrenal failure weretestedusingstudent's unpaired t-test, A p-value less than0.05
was considered significant
TbeslBlisticalsignificaIK:eof~~reLarivesofpatiemsandcootrolsinrarcsofmml
failure wastestedusing2"'2 contingeocy table and oddsmtio(AppcndixE) (Jaesc hke. 1995).
Relativeriskestimates the magnitude of an associalionbetweenexposureand disease and indicates
the:probabi lity of deve loping thedisease in the exposed group compared to the non-exposed
group. Arelative risk greater than I.Oindica.tesapositiveassociation. Becausepersoestecese-
control studiesarechosenby virtueoflheir diseasestatus it isnotpossible 10calculatetheriskof
development of diseas e given thepresence or absence of expos ure . The relativ e:risk was
estimatedby anoddsratio anda95% confidenceimerval.Whenthelower confidencelimitof the
oddsratio was>1.0 the oddsratiowasconsideredto bestatistically significant. Theequations
used to calculate relati ve risk and odds ra tio can be found in Appendix D.
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5.3.2 Es.dasioQ criteria for sta tistical ua.ly1is
Because thisisan iIM:stigariOl1 of familialriskof oon-Mendd.ian foons ofESRD. probandswith
aknoYmMeodelian p!Il2tm ofDWritaoce fix' theirraW diseaseereexcludedfn:m analyses.These
mdudoaUpotiem<tiagn<oed"""""""""'"__~ ","",,,,,,",,,{u=30l.A1polts
>yndrome(...181.Clmn:c<MarieT_""'""'(u=21.byp<roxaI.... (..21.2.8~
disease (n- 2). Berdet-Biedlsyndrome(n-2) andCaroli Syndrome(n-I). One proband with
ESRDdue:to interstitialdisease isexcleded from the analysisbecausethisproband belongsto a
family in whicb autosomal dominant polycystic kidney disease occurs. One proband with
hypertensiverenal failure is excluded because oftheoccurrencc ofrenal failure due to Alport's
syndrome inseveral first degree: relatives. Including the family historiesof thcse two probands
wouJdbave spuriousJyelevatedthepreva.lenceratcofrena! failuteamoog relat.illCSofprobllnds.
InfOd"ofthecontrolfamilics,asingJo-genedisorderIeadingIOESRD\W5prc!iC11l Thrtc oftbese
controlsbdongr:dto familieswithastroashistoryofpolmstic kidneydiseaseand the fourthbad
scvenJfamilymemberswithAlpomsyodromc. Thescfourfiunilicsarcacludedfromanalysis..
3.3.3 Cases wllo refused to putk ipate or could not be located
Probands(n=84)andcontrols(11"'85) that could notbelocatedor refusedto participate werenot
analysed It shouldbenotedthat for6oftheeligib le ESRDpat ientswhocould not belocatedor
refused to put:icirme. raW fai] ure inanotherfamily mcmbc:r hasbeenp-eviously documcntr.d in
the proband's medical record .
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Chapter 6
PROGNOSIS OF MENDELIAN RENAL DISEASES FOUND IN THE
NEWFOUNDLAND PO PULATION
Inheritedrena.ldisea.sewastbecauseofESRDin6.?OlopatiemswhostarteddialysisinCanadain
1993 (CORR..1993). In thepresent :study, Mendeliancunditiuns 'M:re responsible(or 8.2% of
all cases receivingESRDtreatmerrtbetvn:en 1987 and 1993. Byfarthemost f'requentcause was
autosomaldominantpolycysticIcidnc:y disease(ADPKD). followedbyAlport'ssyndromeand
other raregeneticdiseases such as Catoli syndrome,2,8 di-hydroxyadeneine, Charcot-Marie-
Toothdisease ,hypcroxaluria,andBankt-Biedlsyndrom c. Theclinicalcowseofseveral ofthese
conditionsisrelativelywell desaibed;although thatofBardet-Diedlsyndromeisnot Thischapter
will briefly describe the prognosis of the Mendelian disease s identified in this population.
U. Aytowma ! domiO Apt ool ysy,tir kidney d imS
AutasomaI. dominant polycystic kidneydisease(ADPKD) is among the most eottmlOn autosomal
dominantdiseases in the world,occurringin III 000ofthe populationADPKDwasresponsible
for 4.S% of the Newfound land ESKD population betwee n 1987 and 1993. It invo lves cyst
formalion inthe kidncy!l., liver. pancreasand !lflleen. Threefunn.s of ADPKDhavebeen identified,
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invoMrIgrmntioos.udiffaaltioci. wbicbdl:ffi:rin-ODSdofS)'lDl*XnS.. Itisestima!edthat85%of
ADPKD isduelDmutatiOOSaltbcPKDIIocus(Reeders.I98S)and 15%duetoPKD2mU1atioos
(Pelcrs.1993). Stb;equent!y,a fcwfamiliesbawbcendescnbcdwWc.baregeoeticallydistinct
fromPKDl and PKD2 (Daoust eeai, 1995; AlmeIda et el, 1995).
ESRDistbcmostseriousmanifestationofADPKD. lbereisavariarioo intheclinicaJcour!eof
the diff~ PKD fonns . Comparison o(PKDI and PKD2 have shownPKD2 to be a milder
condition(Parfrcyet aI.199O). The natumIhistoryofPKD I includesthe developmemof renal
cysls bdi.xetbeageofJO. wrth sOOscqucntlbelopnenl of bypenensi on,~ by renaltilillR
in the: fourthand fifth decades. FSRO occurs about 10 years after tbe devel opme nt or renal
impUnnent life cxpectaneyofPKD I isapproximatdy67 yeacs(Parfrcy, 1993). In PKD2,lhe
mean age of onset ofESRD ina Newfoundlandpopulation wasfound:to be68.7 years(Bear et
at,1992). Newfot.n:ilaDd dalasbow oociiffi:ron:bctY.tt:nmaJcsandfc:maksforOl!Sd.ofE"5RD
(Pri<y<to1, 1990~~. _ ......"""shown male_lObo_with....,
renal function (Gabo w et al , 1992; Cboukrounetal. 1995 ).
HypertensionisanothercomplicationofADPKD.whichmayhasten renaldeterioration(Gabow ,
1992). Parfrey et at(1990) fowxl hypertensionoccuned in2S% ofchildrenwithcystsandin62"10
ofadults with cysts; simi lar to the fmdingsof other investigaton (z eirer ei at.1988).
§.J Alport. mdmmc
Alport's syndrome is an inherited, bcmaturic, oonimmuncgIometulooepbri characterised by
progressiverenal fail~, in which oeurosensorybearinglossand ocu1araboonnaIitiesmay also
occur(SchrierctaL,I993). The syndromeisgcneticallybeterogenous. Thecomroonestmodeof
inheritanceisX-linkeddominant,less fn:qucntlyit isautosomaldominantand rardy aurosomal
recessive, Pabcmswith Alport'ssyndrome coostitule.d. 2.3% ofESRD pubm:Is in the present
..my. """",,,,!be '""""'""'" lOundunoog~poti""'''!be''''' dime (Mi1IiDo"
et al, 1982).
The clinicalC('IlJJ"SC ofAlport'ssyndmmediffersformalesandfemales.The renalprognosis ismuch
more severe in males. Microscopic hematuria is present at birth,or shortly after, in almost all
affectedmales.Renal fun:tioninevitablydcteriora1es aIXiESRD0CCl.lI3 roughly6 years trom0DSd
ofdeclineinn:nalfunction (Gnmfeld, 1985). Males typicallydevdopESRD I:Jctv,,:a:a the ages
of IS and40 (Grunfeld,1985). However, thcreare reponsofcases where oeset occers at an
earlieragc (Gnmfdd et al,1m }. 'tbee isa widcdinic:al spectnan ofre:naI invoIvernenIin femaIc:s.
Themajorityha'oCsligblW'inary abnormalities wilhnosignificaDI.renalimpairmenl Fcmalecarriers
can beasympromatic. Afew affcceed femaleshaveprogressiveneph ropat hy. developingESRD
between the ages ISand 30 years(Grunfeld, 1985;Schrier et al, 1993) or earlier(Schrier et al,
1993).
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E gbt=A1port's>yndromeprobands,limr 10famiIi<s. .... idonrified;,,!be po=moudy. 10
~malcmd8 female. Age ofoasetofESRD formak:s~ from l8-(7)UlS with a mean
of32..7yean..Fortemalcs.,theagcofonsetranged from. 1&-60 with. meanof35.0 years.. The
medic:aI recordswere reviewed toconfum the diagnosisin aUAJpon's cases . No attempt was
madetodetermineagcofoosctofsymptomsintbcaffectcdS1blings. ODgoingmolecuJargenetic
Iinkag<anal"" byYounget at(unpubli>hcddamA. Memorial)indicatesa X-IinkOOOOmllwrt
patternin6 ofthesefamilies.,and hasruled outX-linkedtransmission inone famil y, inoneother
familythepattern of inheritanee could not bedetermined. Theremainingfamiliescouldnot be
enrolled for linkageanalysis.
~ Cb .rt;QC. M'rif-Toolb d i1cac
Owcol-Marie-Toothdisease isa pogrcs:sivemolor andsensory neuropathyusuallyinherited in
an autosomaldominant pattern(Iboc:ne. (995). Its global~c:ncc is estimatedat 112.500
(Ilw::ooe. 1995). Rcoa.I abmrmaliticsbavebeeaobseved asac:omplicatioo oftbcdiseasc:in a few
indivKIuals(Gbc<a<fi et at. 1985; LcnUcux" at. 1967).The""""" oudy as=uinod a _ ond
daughterpresentingwith renaIfailuresecondary10Charcot-Marie-Toothdiseaseat ages28and
16, respe.ctively. AclmicaJdescription ofthcsetYo'O pstientshasbcenpublished(Paulet al, 1990).
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~ H ypcroglp ria (Oylosbl
Hyperox.aluriaisaoautosomal~'ledisordercharacu:risedby~urinaryexcn:tiooof
oxaIicacidLeadinglOoulatecrystalsandsrooes(Theooe.I99S). ClinicallIWlifesratioosusually
firstoccur Inchildhood, butmayoccur ininfancyoradulthood..Progressiverenaldamage occurs
at a young age(Hocbdayc:t al, 1964). T\W male probands. fromtwo separate families. M;re
idenlificdindrispop1lation. Thc:seindividualss:rogn::ssc:d to n::nal fili.lureat 7 and23 ycarsof age.
The ir successful treatme nt with rena l transp lanta tion has been desc ribed (paul et al, 1987 ).
M 2.x Djbydm n ldcnjgc uroljtb iM jI
2.8 I'>ihydroxyadenineumlithiasisn::sultsfTom anautosomalra::c:ssM= me!abolicemymedr:ficierq,
r..""__odonIDc".,...,..,.._"""""""' (SUnmoods,..I.I99 n _y
90 familieswith thedeficic:n;:y ha...e been identifiedinNortbAmcrica.Europe.Japan andAusttalia.
TbetnJeincidcnc:c:oftbcdisordcr isunknown.bccause~stoocs~ DOtroutind.y analysed for
the presence:of dibydroxyadminc:. The fortnationof these stones results in a wide di\'CBity of
clinical. manifc:statioos - symptomScanrangefn:m absence ormikllOJoogstanding rmaJ. damage.
Kamatanieta! (1987) reportedameanage at onset of24.9 years(ranging8 months - 72 years)
forsymptomssu:.h as hematuria.~colic. dysuriaandurinarytraetinfcctions. The disorder may
leadto renalfailure(Kamatauiet al,1987; Manyaket al, 1987;Glicklichet el, 19888; Fyeet al,
1993).LongUndinguro lithiasis led to renalfailureU llg'CS 72 and 75. respectively, fora brother
andsister who wereidenti fied as probandsin this study (Gault et ai, 1981) .
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§..1 Budct_Bicdlrndmmc
Batdct-Biedlsyndrome (BBS ) isa rlft autosomalrecessive disease. Tbrcc distinctgenes baYe
been tdentifiedascausingthissyndrome. Ongomglinkageanatysis bas iDdicated tbata posstble
fourth gene may be invol ved (Y oung et at.unpublished data B).
The syndrome is characterised by dysmorphic extremities, reti nal dystrophy, obesity,
hypogenitalismin metesand renalstruetuml abnormalities (Green et ul, 1989~ Two probands.
from separate families, had BSSas a causeof ESRD in the present population. Becausethe
clinlcalcour.;eofthiscondition is not welldescribed. 38AR.C;; patientsand58 unaffectedsIb lings.
from 2 1fa.milies in Newfoundland. wereprospectivelystudiedas put of my Mastet'sworkhas
recentlybeen p1bIisbc:d in theAmD'ican JQID7IQ/ of Kidney Diseases (O'Dea et al,1996). A
copy of this paper is appc:oded(Appendix E).
BBSbasanadversc prognosis, withearlyonsetofblindnc:ss. obesi ty, bypcrteDsionanddiabetes.
SOO.4ofpatientswere legally blind byage18 and 100%byage30 (O'Dea ct al , 1996). Obesity
ispredominantlytruneaI and ispresent fTom early childhood (Green eeaI. (989). Hypertension and
diabetesoccurearly, with 50% of individualsbecoming hypertensivebyage 34and 50% becoming
non-insulin dependent diabetics by age SS (O'Dea et at, 1996).
••
Structuralrenalabnormalities havebeen observed in up to 100%of patients reportedinclinical
series(Hamettetal.., 1988). 2S%ofBardet~Biedl pstientsbadimpairedglomeru1arfiltrationrate.
and in the group with normal renal function. a further25% haddiffuse cortical loss on renal
ultrasound Theearliest ageofonset of chronic renalfailure in these Newfoundland patients was
2 years.Othercasestudiesbavereportedevenearlieronset(Bluetetal.., 19n ;Tieder et al, 1982~
Linneetal; 1987). Life expectancy was reduced in theseindividuals. witb25%dying by age44 .
In theeiglndcatbsobserved in thisoohort study, 3 resultedftomESRDand 3 wereassociatedwith
chronic renal faihue (O'Dea et al, 1996).
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Chapter 7
RESULTS
1..1 Ba:selipe Re3ul b
7.1. 1 Proband population
UsingCORRand hospital rcgisbics.669base1ineESRDpatientswereidemifiedaseliglblefor the
study. This groupis representative of theentire Newfoundland population,encompassing all
geographic areas of Newfoundland and Labrador. Family histories were collected on 584
(87.3%)ofeligtblepatients., whoarereferredtoasprobands. Sixty (9.0% ) patients could notbc
located, and 25 (3.6%) refused to participate.
The mean age ofprobands beginningESRD therapy was50.1 years. lower than the national
averageof57ycars in 1993 (CORR, 1993). TbeagerangeoffustESRDwas2-87yearsofage.
32 of the probandsbegan ESRD treatment beforetheageof 17. Mendelian disease8CCOWlted
for 60% of these 32 probands. ESRD wasmore prevalent in ma les (62.9%) than females
(37.1%), similar to other studies (Silliger, 1995). Males began ESRD at an earlier age than
females. All except one patien t wereCaucasia n. The majority ofprobands received ESRD
treatment at theHSC (59.5% ), followedby the SAGGH (28.4%) and WMRH(12.1%)(Table
I).
'1
7.1.2 Can.diad Organ Replacement Registry
70.4% (0'"'471)ofeliglble patients hadbeenregistered withCORR(fable I). Therewasa low
registtatiOQ nne forpttiems at the SAGGH(46.SO;'). Patientsat WMRHwereidemified pimarify
throughtheCORR registry, whicb may accountfor the high registrationrate seenfor thiscentre .
7.1.3 Contro l popUIaOOD
Family historieswerecoUectedon 85 .4% (499/584 ) of the eligible spousesof probands. The
majorityof controlswerefemale(59.1%) (asexpected forspousalcontrolsof a dis\:l'oportionatcly
mal e group). Nospouseoranynextoflcincould belocated forM potentialcomrols( I I.O''Ia)and
20 (3.4% ) decl ined 10 part ic ipate.
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z..z Prim,ry Ren. ' DiM:aH iD pmbap4.t
7.1.1 Meltdelia. HI~rited di5euel kaelinC to ESRD
Table 2classifiesthe casesofMendelian diseasesleading to renalfailureidentifiedin this study .
Thesecases represent 8.S%ofbaselinc petieets,similarto therqxxted Canadianprevalencerare
of6 .3% andhigherthan the TqX)ItC:d US~ of 3.3%. Autosomal dominant polycystic
kidney disease was the most common Mendelian renaldisease notod.. accounting for 4.5% of
baseline patientsand 52.6% of the Mendelianpatients. ThisVDlue is lowerthan that forCannda
asa whole (6.1% in 1993), but higberthan the US ratc of 3.2% (CORR. 1993; USRDS, 1'H3).
It shouldbe kcpr. in mind lba1thequotedprewleoce is thai.of ueate:dESRD. It is unknown to
wha1exJentdi1ferencesinrefeml1orac:o:ptmceforESRD~lodifferm~nuc:s
of trate:dESRDin various countries. This rate may becomparati \'dy lowin other countriesas
a result ofinac:curateESRDdiagnosis. This inaa;umcy could be the result of less extensive
searching fora geneticcausefor renal&ilure.TheNewfoundland popUaboohasbeen extensivdy
in\'CStigated formanygenetic conditions owingto its ideal isolated,closeknit popu.laIionbase .
More comprehensive exploring of family histories by physicians who are aware of the gcnc:tic
diseases present in this population may have lead 10correct identification of patients with
Mendeliandisease. Patientswith a Mcnde1.ian C3U5C forrmaI fitilurearelesslikelytbeteforeto be
uncb'1'qlOI'tfd in thedtta registries. Mendeliandisease mayaIsoacc:ountfora smaller-proportion
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ofESRDasaasdtotinaeaslngp-evaJmceratcsofdiabetic:mtbypc::nrnslve renal faillR. This
increase in~ofotber rmal cooditimsmay obscurc a true bigbincidc:nce ofMeodeIian
diseases leading to renaJ fai lure .
Therate ofsingIe-gcne fonnsofrenal disease. otherthanautOSOma1 dominantpolycysticdisease
in thestudypopulation was4.0%; higher thanthe comparable rate of 1.6% ofESRD cases in
Canadaand0.7% in theUSA(CORR., 1993; USRDS. 1993). Alport'ssyndrome is the second
mcsrccmmcaceese ofMendelian rena.I diseasein tbestudy population,accounting for2 .7%of
baselinepatients and 31.6% of Mendelian patients. Therewere9 probands with ram-formsof
inheriteddisease leadingto ESRD. includingautosomaldominant Cbarcot·Maric--Toothdisease
(n-2)aut"""""'="eBanlet.BicdJsyndrome(n-2~ 2.8 dihydroxyadeninine Ws=e(...2~
byporoxAI.ma(n""2)and CaroOsyndrome (...I) Thedelailcd funiIy """""" taikdlD idcmifY my
families with previously unrecognized Mendelian inherited disease.
In thata major goalof this studywas to gain a betterundemandingof genetic liability in non-
Mendelianformsofkidncyfuilure.,the remainder of thisc~win excludefromanalysisthe 57
probandswith Mendelian disease and discuss thoserenal diseasecases which do not appearto
arise&omsimpleMeOOeIian inheriuw:e. ThefamilybisIoricson52oflvk:nddianplIienl'sspocses
wereacquired and used as control family cases.
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1.1.% Pro baods witbo at Meod ellaa diseue
SimpleMendelianpmemsofInberitm:ccamotbeusedto explainthe majorityof casesofESRD
in NewfouMland. 9 1.5% (D""'612)of~ did DOt ba\'Ca recognisedMeodelian form of
ESRD (fable I). Oneoftbe forms of primarygiomerWooephritaa:otJnted for ESRD iD25.1%
of our eligible patients . Thenext most prewleutcause of ESRD wasdiabetic nephropathy.
accounting for 19.9%ofeligible patients. Ina~ proportiOl] ofpatic:nts(14%) an underlying
causeofESRDcould ootbedetermined Tbesethree catego ries accounted for 59.3% of eligib le
potients.,similartonational registries(CORR.., 1993; USRDS. 1993). TheothcrcausesofESRD
instUdypop.dation~ shown in Tab le 1. Family histories weecouected oo.S32ofthe baseline
pat ien ts. Tab le 3 shows the dia gnoses for these probands.
7~1 Glomeru looeptlriti!
168ESRDpatiems 'M:rC: idemifiedin v.bic:b t!:J::: originalrmaI disease wasgiom:ruIor:qiDiand
famity historieswerecompleted in ISSofthcsc:cases(Table 1&. 3). Similar 10the findingsof
other investigatOrS, males madeup. grcaterproporrionofGN cases than fema1es(pzO.OOO4)
(Silbiger et aI. 1995). Themeanage giomerulonepbritisJnlbands enteredanESRDpogram 'MlS
44;!:.18 yean. with nodifference between sexes. Age at tim ESRD treatment ran ged from7 to
nyears.
7.ll1 DiI~mellitus
Diabeticsare classifiedas crtber type I (insu1in-depende diabetes mellitus. IDDM) or type 1I
(~di.abetcs mellitus, NIDDM). T)peD is tentimes morefrequentiDtbe
geoeraIpopulation thanI)'pe Lbas• much stronger familialriskand isassociated with insulin
resistance (McPhee. 1995). Although both type [and type Il diabetics suffer the co mplete
spectrumofdiabeticcompIiearioos, the occurrenceoftbe:sevaricswitheadl type.~ty
30%of type Ipatientsultimatelydieofrenaldiseaseor requireESRDtreatment (Anderson etal,
1983; Kro lewski et al, 1985). Type D diabetic patients seem to develop renal failure less
ticquentty thantype I patients . AlthoughESRDoccursmorefrequentlyin type [ than type II
r-cients.,type n puients account for . greater proporrionofthc:FSRD populationbecause ofthc
gtcalct prevaJencc: of type ndiabetics. Type n patients accounted for 1 1 . 2% (D~58) of tbc
bBselinepatientpop.dationm:! S6.4%oftbediabeticESRDpopulation. Typelpltic:ntsc:onst:itule
8.7% (r75) ofbasclinepopula.tioo(Tab le I). We werc:able to collcct family bistorieson 114
base line diabetic ESRD patients (Table 3).
ESRD attributed todiabetic nephropath y affects moremalesthanfemaJes(males:n-8 1;females:
rr-S2). Diabeticswithtype Idiabetesprogressed to m1llI failureat anearlierage thanpersons with
type n diabetes. The mean ages at which diabetic type r and n patie nts commenced ESRD
therapy were 39.5 yean (range : 21-63) and65.8 years (range: 50-87) . res pecti vely.
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't.1.1.J fmontin.1disease
1Illerstitial diseaseaccoumedforESRDin lO.S%(n=70) ofbaselinc patietJrs; it was possible to
""""""_lriso>rie;on6IoC"""'_(T_ l "'TablcJ~ Plimuy~retIux
aa:otmICd fOr45.7% (1F"34) ofprobInckwith imeIsIitiaIdisease (5.1% ofbBsdinepI!l:iCDls). The
majuity of reflux prt:ic:nt:s VoCe femaJe (r2S)andthe meanageof omct ofE'SRDforbodtmales
and femaleswas27.3 yean. Nephrolithiasis\VaS the cause forESRD in 12 probands (1.8% of
baseline patients},ofwhom6 weremale and6 female. The averageageof renaJ. failure in these
potients was 54.7 yean (range: 32-74). No attempt was madeto diagnose specific stone
disorders.For I I patients.,tuberculosiswasresp;msibleforESRD. SeveraJpalientsbada history
of rena l tuberculosis lead ing to renaldamage with other renalcomplications also predisposing
indiviWalsto ESRD. Tbcsc:patientswereclasslfiedas having multiple ClUIS(S ofESRD. In 13
cases. pyelonephri tis was the cause.
Sixty-se\-enpercent(D""47)of pui em:switbinterstitial disease ....ere fcmaIes(p=O.04). Patients
with imerstitiaI disease had the earliestageofonset ofESRD of studycategOries. the meanbeing
36.S!.18 .4 years (range 6-76) .
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7.2.l.4 BypertellJivc aepbrosderMis
Hypertensivenephrosclerosisaccountedfor8.9"/ooftheCanadianpopuIationreceivingESRDin
1993 (CORR, 1993)eventbough weincludedn:oovascu.lardisea.se in thiscategory. This small
groupsubgroup bad preexistinghypertension. Therate ofn:novascu.lardisease as a cause of
ESRD is probably rising. lIS the age of patients startingESRD therapyincreases. Our rate is
probablyanund:rcstimate because we usedastrict~aiteria. whichallO'M:d assigmnent
of patients to this category only if sufficientevidence was docwnented in thepatient's medical
record Of the hypertensive group. 5~!G were female (p=O.0475). Themeanageof onset for
renal fililure tor this group was69.8~ 9.3 (nmge : 41-81) yean orage, higberthan for any of the
other categories
7.2.2.5 Other
Othertypes ofrenaldiseasewereresponsiblefor12.4%(n=84}ofbaselinepatients.for which 71
fami ly histories were completed (Table 1&. 3).
ObstructiveW'Opatby wasresponsibleforESRD in 3.70/0 (lF25) of the population Underlying
causesofobstructivelII1JPIthy in thebaseliocpltients included neurogenic bladder(TI*4), posterior
urethralvalves(rP5), spina bifida(n-3). spinalstenosis (n=2). prostatic hypenrophy(l'F2)..ileal
conduit obstruction(rr- I),bilatcralmegaurctcr(0-2), 0I:hcrcongenitalobstruction (0-3) ao:iother
acquired obstruction(n= 3). Malescompriseda significantly greaterproportionof obstructive
'9
ESRDpttients thanfemales(p<O.OO5). Themeanageofrenal railureforparienlS with obstructive
ESRD was41.S (range: 4--77) years .
Amongpatients with an autoimmune etiology(IF I? ; 2.5% of the baselinepatient popu1ation),
systemic luptl'>erythematosis( n-S )'pulmonaryrenaldisease(n=5),sclerodenna(D""2).vasculitis
(n=2), polyarteritis (Il""l) and cyrog1obuHnemia(n= I) were found.
Malignant diseases ca used ESRD in 2.1% (n= 14) ofbaseline patients .
tetrcgeruccauses were responsible for a small proportion of cases(1.8%; n=l2) .
Miscellaneous awsc:sof'ESRDaccowned for2.4% (n-16) ofbase line pltients.and included such
etiologies as amy loidosi s (n"'2) and hemolytic uremic syndro me (n-I).
The meanageforESRDobservedforpatientswithintheOtbercaregorywas5~17; 66% were
male.
7.2.2.5 Multiple Causes
Twenty eight baseline patie nts (4.2% ) were identified as having more than one underlying
dl=tmninantofESRD(fable I). Familyhisturit:S Wt:R::takmfur2S ofthl::se28patients(fable 3).
The mean age ofonsetofESRD in thisgroup was67.6!.8.2 (range :52-81) yean; with equal
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numbers of males andfemales.
7.2.2.7UDkDowa
The prinwy origin ofrenaldiseaseleading to ESRD could not be determinedfor 14%(0=94 ) of
baselinepatients,similarto national registries(CORR. 199 3) (Table 1). Familyhistorieswere
collectedon n oftbesepatiems(Table 3). Ofthesc patients. 63.6% arcmale. Themeanage of
renal failure was 58.6;t18.7 yean. with a wide range (8 to 85 years ).
LJ. Prevalence IUd 'tmili,' elk of ES R D . m oo g [Clatjyp
Familialcluste:ringof renaldiseasecan be assessedintwo'Ml)'S. One is tocomparetheproportion
ofprobandsard controls reporting a familylUstolyofESRD. regardlessoCtilenumberofrelatives
affected A better approach is 10compare the proportions of flrst, second and third degree
relatives positive for ESRD in proband control families.
7.3.1 Prevalence of ESRD in families
In lhis study , I I.CJO/o (631530)ofprobandsbad a firstdegree relativewith ESRD.9.1%(48/530)
had a seconddegreerelativewith ESRD and 8.3% (441530)had a third degree relative with
ESRD (Table 4A). The percentageof probands having at least one relative with ESRD was
27.7%( 147/S30}. Of cootrois. 2.8% ( 14/49S) bada firstdegree relative withESRD, 9.1%
(45/ 495 )hadaseconddegrec relativeand2.SOIo(141494) hada th ird~ relativewith ESRD;
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14.7%(73/495)hadalleastoocrelativewithESRD. ESRDwassignificantlyassoc:iatedwiththe
presence ofrena.lfailureina fusedegree relative(OR:4.63, p<O.OOOI ; Table 48 ) and thiIddegree
relative(OR3.11, p9l.0003; Table 4B), but not fora second degree relative. Theproportionof
controls with a second degree relative with ESRD was surpri singl y high .
7.3.2 Prevalence of ESRD among lint, second and tbird degree relatives
1.20"10 offustdegree reJar:ivcsofp'Oband'> badESRDcompared to 0.390/0 offirst degreerelatM:s
of controls (Table SA). A person's risk ofdeve loping renal fai lure leading to death or renal
replacement therapy, if a firstdegree: relative bad renal tiIiIure, wasncarly threetimes tbat ofthe
controls (OR=2.96; 95%CI: 1.7-S.2) (Tabl e SR). Nodifference wasobserved when risks were
comparedfor second.degree relatives. buta significantincreased risk:wasobserved for third
degree relatives (0.37% vs 0.18% ; OR =2.06 . 9 5% CI: 1.2-3.4; Tables SA & 58 ).
7J.J Familial risk of ESRD by cause of ESRD ia probaod
The0CCUl'I'enCe of renalfailurein relativesof probands accordingto the etiologyofESRD isshown
in Table6. Theriskof ESRO in first degree relatives is highestin families of probands with
hypertensive ESRD, interstitial ren al diseas e and diabetic nephropathy.
M CD!IlUImJlI
Thenumbersofaffectedrelativesof probandsand controls registeredwith CORR is small,butthe:
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tn:ndsare consist:enrwiththe familyhisloryda!a(Table7). First.degmerelativesofpobands~
twiceas likelyto be registered with CORR as first degree relativesof controls. Seconddegree
relativeswerethreetimes as likelyand third degree relatives2.4timesas likdy toberegistered..
~theriskofaprobandhavinganotherrelativeregisteredwitb.CORR was32 timesthatfor
relativesof controls (JFO.002).
.u ESBD ig ' amj!jq of orobapd, I nd m utro" venus tb e ge ne n l IJOPDI,tjog
TheNewfoundlandprovincialincidenceofESRD. as registeredwith CORR, from 1981-1993.
was79lmilliorVyear,excludingp!tients withaMendeliandisease(CORR. 1993~ The rate ftrfirst
degree re latives ofprobands was297/mi ll ionJyear. a lmost four times the general population rare .
Thecomparable rate for first degree relatives in controls was13Slmillionlyear.
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Chapter 8
[S THERE A FAMILIAL RISK FOR ENDSTAGE RENAL D[SEASE?11.1_
Asaclinicalcntity,ESRD,is cbar.lacrisedby pugnssiverenaldysfunction lcadingultimalelyw
kidney failan mquiring JlCISOO5 to bemaimainedondialysisorundergo transplar1IBtio forSl6Vival.
The~eoce of treated ESRDbas~substantially overtbe~ decade. making it an
Unponantchronic disease in1em1S of morbidity, mortalityandmonetarycosts, Despiteintense
research, theetiologyofESRDremains to a largeextent unknown. Disease: followingaclassic
Mendelian patternof inheritance appear 10beresponsible foronlya smaU percentage of cases
(CO RR, 199 3; USRDS. 1993 ).
EWienceisaccumulating to demonsmtc theroleof geneticfactors andgenetic-envirmmental
intenlCtions intheetiologyand pathogenesisofoommonhuman diseases. includingrena ldisease
(Khcuyetal . 1993~ Thisisattnbumbleinlarge partto advanccs inmoIccuIarbioiogy, whichhaw:
""!"""Icd....wxl=lanWngofdiseases"1bc mol=lar lC"Cl ondJmoe facilitaocd ....._of
the genetic nature o f many common diseases.
GcJetic susceptibilityincommonfunnsof remIdisease issuggc::stJ::d bytheapp::arance ofdUSlC'S
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ofreua.ldisease ine:enain families (Julian et al, 1985 ; Ferguson et al, 1988; Seaquist, 1989;
Stcenlaod era1,199O; 8oR:b-Jobnson et al.l~Quinn et at, 1992 ; Freedman erat, 19938;
Sprayetal, I99S). Becausc:thcydonotappeattosegrega:reinacIassic:Mendelianfashion.somc
formsof these diseaseshave beenconsideredto haw: • muttifactoriAJ liability. reflecting the
interaction of multiple genes with environmental infleences
U Gl9 memlopcpbritil
Giomcrulonephritis\W$ themostcommoncauseofESRD identifiedin thispopula:tion.Although
11 strong genetic linbilityto gIomcru100:phriris \\QS not indicated in the present data- 0.76% of lir5t
degree relatives hadt::SKlJ . othercpidcmiologjcal studies suggest. genetic pmiispos;ition 10
glomerulardi!"a."oe. 26%ofglomerular ESRDprohando; in thi!l~ had a tim, ~orthird
degrce relative with renalfailUR:_Thi ssuppor1Stheresulu foundby Spray d aI (199S). In thei r
stUdy.24%ofCaucasianpatients withglomerularESRDhadeither. first. sccoodorthird degree
n:lativewithESRD. Frecdm.and al( I993B)observedasmallcrproportionofAfrican.American
glomerularESRDpatientsbavingotberfamilymctnbcr.; alsowithrenalfailure;14%had either_
first, secondor third degree relative with renal failure.
Thereisevjdence of fiuniliaJ and genetic liability tospecificg\omenJ.lar diseases. Julianetal (1985)
foundthatat least lSO/OofKentucky..oomIgA patients belonged to poteutial1yrelated pedigrees.
6'
The clllSteringof IgA nephropathy in these cases wasDOt restricted (Q individuals sharing •
common eov1romnema.I factor. FamiliailgA nephropathy basalso been describedin German
(Rambuseket al, 19m Japanese (Nomura er al, 1993). Freocb (Cbarasse et a1., 1993) and
AustralianAboriginal(O'ConneUet at.1987) families . CertainHLAalIdes Me rD(R fuquem
amoogJlBtient3 affectedwith IgAnephropathy than controb (Tolkoff-Rubinet al, 1978;Sabener
et ai, 1979; Katzet aJ.. 1980; Kashiwabara et al, 1982; Nomotoeea!.1984; Naito et al, 1981;
Julianetal I989 ; Hikietal. 1990 ; U ee. tssz.Frecdman.et al l994A: Pei et al, 1995); these
antigen markersfor 19A nephropmhyvmying with racial. group. Recently. an increase in lhc
A<.r r rrr polymorphism of tbe renin-angiotenin system was found to poss ibly increase IgA
~mcertainpaticntswithlgAncphmps1hysuggesti"8ap(lssiblegcneticdeterm;nant(Pei
et al, 199').
family studics,.mimaIinvcsti{;atioosm::lHLAassociaticm.suggat a gcn:ticroleinfocalsq;martaI
glomerulosclerosis(Zimmerman et al. 1 9~Agar et al. 1980; Walker et at, 1982; Kikutad aL
1983; Trarminet al I983; Weening et al. 1986; Gl icklichet aI. 198M; Freedmanctal l994A).
~""Iif=ti""giom<nUoocP>ritis(Kik...eta!, I9D )and"""""",",g1omeru1"""",",,,
(Klouda ct al, 1979; We1chetal.1986; Naitoetal, 1987; Huangetal. 1989; Ogabaraet al, 1992;
C lark et ai, 1993; Sack s et al, 1987; Freedman et et. 19948 ; Muller et el, 1995;).
Few of the patients of the present study were biopsied or fell neatly into one of the
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gIomtruIorqiritclassifications Thefamily dal:a wasanalysedin aggtega!C 10 assess whether.
~toprogn:s.siveglomerul"""l'britis""'"""'wlthinlbebroad_ofchronic
g1omero1onepbritisdis<osc. nus bclcrogeneitymay ""'" _ incrca>ed &miliaI risks of
specifi c types of glomerular diseases .
Several investigators have postulated that it is not I genetic susceptibi lity 10 develop
g1omcru1"""Pbritis"such.bu!13lbera genoricpredispoottiontod=lopbypertensKmwhich intum
producesglancrulm-__di1f=nlgenoricmcchmDsmsJRdisposmgindMdualsto_
hypertensiveonthe onebandand develop glomerulardamageasa result of bypcrtcnsionon the
otherhand(Dworicinetal,19R6;Sch midtetal, I990 ;Cusietal,l993). Theinteraerionofthc:se
distinctgcnc:ticmecbanismswiththen:stoftbe~andtheenviroomentcouldmao.ifC3las
distinguishable etiologiesof ESRD. Schmidt et al (1990)proposed increased genetic risk of
hyp:rtc:nsionin gIomeruloocphritis patients basedon the observation that the prevalence of
bypent:nsioninparentsofglomcruloDcphritis patients wastwic:etbatforconttols. DworkinetaI
(1986)obsc<vcddi1li=mal d=lopncnt of gl_ damageindi1f=tt snains ofltypo1ensM:
rats .
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U Hyperteg!ljyc pepbfO!!C1erosja
In thepresentstudy , thegroupof probands who were classifiedas baving ESRDsecondaryto
bypertensi>e"""""",_orrenalvasculardisease werefoundto ""'" the hi"'" fiunilialrisk
of renalfailure. 44%ofthe probandsin this group hadanaffectedrelativewithrenalfailureand
2.S%oftheirfustdegreerelativeshadrenalfailure. It is unclearwbetherthefimilial riskassocaied
with hypertensionand ESRD results from true hypertensivenephrosclerosisor from vascular
causesof renalfailure. It is well documentedthat therearesignificant racialdifferencesin the
incidenceof ESRDfromhypertensive oephropnthy. with up to a 20- fold increased risk in the
black population compared to the who le population (Qualheim,. 1991; Mclellan, 1989~ This
difference doesnotappearto beexplainedby race related differencesin the prevalence, ageof
onset or severityofh ypertension( Whi ttle, 1991), Withinablackpopulatiooevidenceoffamilial
risk for ESRDhasbeen reported . Ferguson et aI (1988) foundlhatESRD wasassociated with
the presenceof hypertension and chronic renal failure in first or second degree relatives of
hypenenstve ESRDpttients ina subsetof AfricanAmerican families, They suggested a heritable
liabilityin thissubsetoffamilics. In a studycomparingprevalencerates ofrenal failure among
relati'tleS of I31AfricanAmericansgroupedbyESRDetiologyand liS age-sexandrace-matched
control s without ESRD , the grea test familial risk:was found for patients wit h hypert ensive
nephropathy - 4()01ohada relative with ESRD (freedman et el, 19938). These find ings were
supportedbyBergman andcolleagues who detenninedthat24% of African American dialysis
patientswithc linicallysuspectedhypertensive nephropsthyasthecauseoftheirESRDhadafil'St
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degree relative with evidence of nephropath y, i.e. eleva ted serum creatinine or proteinuria
(Bergman. 1996). Freedman et al ( 1991) found an increased frequency ofl-U..ADRJ among
black hypertensive renal failure patients.
It basbeen postulated that the kidney in blacks, comparedto other races,maybemoresusceptJ.b1e
to hypertensive injury by virtueofrenal vasculature (Levy et al, 1978). renal hemodynamics
(Frochlichetal,. 1983), renin levels (Dunne et al, 1973)andsaltsensitivity(Dustan et al, 1987).
Further.blackbypertensivesare morelikely to bevolume expanded(Lilly, 1976). Anyofthcse
traits may have an inheri ted basis . and hence a familial influence on the likelihood ofESRD.
Theinclusion of renalvascular disease in thisgroupofprobands complicates the interpretation
somewhatalthoughonly 3 probandsbad this diagnosis and they bad preexisting hypertension.
Atheromatousrenalartery stenosis is associatedwith numerous factors such as smoking and
hyperlipidemia. The role of genetic predispositionto renal artery disease: basreceived relatively
littleattentionto date. Missouris (1996)founda higher incidenceof the AC&D allele inpatients
with renalartery stenosisthanin age.sexandracematchodcontrols (OR:I.1. 9S% Cl l .0-2.8).
Thepresenceof thisallele hasbeenpreviouslyreportedto beassociatedwithcoronaryartery reo.
stenosis in patients who have undergone coronary angio plasty (Ohishi, 1993; Kaski , 1994).
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M Pi. beteI m clljtg:s
In the pesecrstudy,22010 oftbe 114diabetic ESRDpatientsreported havinga fumilymember with
renalfailure.and ESRDoccum:din 1.34%ofdiabeticprobands' relatives. Ifonly~ with
TypeIdiabeteswereconsidered,1.6%offirstdegreerelativeswereaffected.A largeproportion
ofdiabeticsdoDOtexperiencethe renalcomplicationsofdiabetes - proteinuria.hypertensionand
progressiverenaifailure -dcspite longtenndia.betes(Krolewskictal, 1985). Riskfactorsforthe
progressionof diabeticnephropathy include durationof diabetes for both100M and NIDDM
(Nelson et a l,1988),blood glucose level (Krolewski eta1, 1988; Kunzelman et al, 1989) and
hypertensionhistmy(Parving,1981); however. theserisk: fiJctorsleavemuchof the individualrisk
variatio n unexplai ned
Geneticfactorsareknownto playan important rolein theetiologyof diabetes mellitusofaUtypes
(Brosiuset al, 1992;Leahyet ai, 1993). Numerousstudies have shown associationsofIDDM
liability with specific ffi..Aand com plement phenotypes (Brosius et al, (992). Davies and
colleagues (1994)have recently undertaken a genome-widesearch for human type I diabetes
susceptibilitygenesand haveidentified severalchromosomalregionswheresuchgenesprobaly
occur. Separate inheritedrisksmay exist for diabeteson the one hand and the developmentof
diabetic neph ropathy on the other hand.
Ageneticbasisfordiabeticnephropsthy maybeinferredfimnassociationswithfamilyhistoryof
70
hypertensionor cardiovasculardisease (Viberti et at.1987; Krolewskiet at.1988; Earle et al,
1992;S!eJlhen'on",w. I995j,wiIh_ S<Xfium.liIhium=-_ octiviIy(Krolewslri
et al, 1988. Mangilietal. 1988), with race(Tiemeyetal. 1985; HaflheretaI. 1989; Brancatiet
a1,1992).andfrom familialc1usteringof diabdicnepbropathy(Seaquistetal. 1989; Pettittet al,
1990; Berch-Johnson,1992; Brancatiet at.1992; Quinn et a1, 1992; Freedmanet al, 1995A).
'ThemostconviJringevidelaoftbisdistinctioncomesfroma studybySeaquisteta! (1989)whicb
found that 83% of 100M siblings of 100M patients with nephropathy also had diabetic
nephropathy, as compored to 170/0 of IDDM s iblings ofIDDM pea ems without nephropathy.
Nepbropa!hy inthepuband wasthe onlytactorpredictiveoCtilerenal status of the diabeticSibling.
Quinn er al (1992) found that renal impainn ent occurred in 53% of m OM siblings ofpmbands
with nephropathycompaccdto ISOlo ofIDDMsiblingsof diabetics without nephropathy. These
results havebeen confirmedbyBerch-Johnsoneta! (1992) who pointout thattheclustering may
be due to genetic inheritance or sib's-similaritiesdue to sharing the same environment. Mor e
rocentI.y Quinn et at(1996 ) examinedconcordancefor diabetic nephropathy in families with
multiple IDOM siblings. A Sib lings risk of diabetic nephropathy after 25 years of IDDM was
significantly higheru the probandhadpersistent proteinuriatheniflhey did not (7U % versus
25.4%) , which the authors suggest is consistent with an autosomal dom inant effect.
Genetic susceptibilityto NlDDM nephropathy has been investigated extensively in the Pima
Indians.,whoexperiencebotha high prevalence of NIDDM and early age of onset ofNID DM
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(Pettitt et al, 1990). Proteinwiawes ccserved in 45% of diabeticoffspring if bothparentsbad
NIDDMand proteinuria,comparedto 14% ifneitberdiabetiCparenl:hadproteinuria. Therisk
remainedafteradjustment Cor bloodpressure. TheaggregationofrenaJ disease intbesediabetic
familiesIedPettittet at(1990)tosuggestthatsusceptibilityto renal disease wasindepc:ndc:ntofthe
."",plibilityto_I",,_ InAliiamAmericom,Freedmanetal(1995A)found1bm37%
ofNIDDMESRDparicmshadeitb;:r a first.secoodortbird~ relativewithESRD.compm:d
to 7010 of diabetic controls who did not have nephropathy.
It has beenhypothesisedthatin diabetic nephropathyoneor more genes.in combinationwith
environmental fac!Ol'S, is rcquiredto produceclmicallysignificant insulin resistance.whilc:differenl
8ene(S) produce the renal manifestations of diabetes (Seaquist et al, 1986; Freedman et el,
1995A). Susceptibility10diabetic nephropathy is recognisedonly after prolonged diabetes.
Seaquistet at(1986) proposed that thebiochemical abnormality encoded by the "susceptibility
gene"mayinvolvethe metabolismofthe glomerularbasement membrane;diabeticswhoremain
fitt of nephropathyafteryearsof disease must havea metabolismthat can toleratethe stress of
the diabetic stat e.
Another possibilityis thatsusceptibility to diabeticnephroprthyisdue to geneticpolymorphism of
enzymesthatdetenninethecompositionoftheglomerularbasementmembraneandextracelluar
matrix(Deckertetal, 1989}. Accordingtothisthoory,diabeticpetientswith geneticdefects in the
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regulationof theglomerularbasementmembnlne andextracellularmatrix glycoprotein,namely
beparan sulphate prcteoglycan, are at a greater risk of developing functional and structura.I
abnormalitiesthatlead.to glomerulosclerosisandeventuallyclinical nephropathy (Deckertet at,
1989).
S=mlod=_c_fu"tiaticticocphroprttiytiaveb=_mclcdmgWnilial
predispositionto hypertensionas a risk factor. Several studies have found a greaterprevalence
of hypertensionand cardiovasculardiseasein theparents of persons who laterdevelop diabetic
nepbropatby (Viberti et al, 1987; Kralewski et al, 19K8; Earle et al,1992; Stephenson et ai,
1995). Cusict al(1993) proposeaddi tive acrion ofgenescausing high blood pressureand genes
causingdiabetes. togethercausinghypertensionand g1omerulardamage. Otherstudies havenot
supported these findings (Mangi li et al. 1988; Walker et al, 1990; Norgaard et el, 1991).
Becausesodium-lithiumcountertranspOrtactivityishigherinpatientswithdiabeticnephro~y
comparedto thosewithout(Krolewski et al, 1988; Mangilieta1, 1988; Walkcretal l990},higher
ina largesubgroupofessential bypertens:iveparients(Canessa eral, 1980). and hasa geneticbasis,
a geneticprMisposition to hypertension or sodium-lithium countertransport actMtycoukl. increase
the susceptlbtlityto reoaldiseaseindiabetic perentsand couldbeconsideredasa possible marker
furdiabeticnepbropalhy. MicroaIbuminwlcpatients,a groupat highrisk:of developingovert renal
disease,havealsobeen found tohaveincreasedrates of sodium-lithiumactMty (Joneset al, 1990).
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No«all investigationssupport thesefindings(Jensen et al, 1990; Elving et all992). Jensen's
(1990)SlUdy fouodina<a=!sod;um-lithium=-_ _ fo<_ _ potiems
~ilh nop/n>palby and _ "'""'" treeof nop/n>palby,I<ading1be<e,"""" lo """""," !hal
the inc:reased activity may bea oonscquenceof diabetes per se andnot a risk marker for the
development of nephro pathy.
The D-alIeleofthe ACE gene(Bamas et al, 1995)andHlA associations(freedmanet all993A)
have also been suggested as possi ble risk markers for diabeti c nephropathy.
y ' "t cooP. 1d iaR
Geneticsusceptibility appealS 10 be relevant in the development of ESRD in probands with
intmtitial diseasein the presentstudy. 34% ofprobaods with interstitialdisease reported renal
6u1un:asoccurrinsinafirst.sccoodortbirddegro:rdatiYeaOO 1 .4%or6rstdegro:rdarive:s~
affected Other invcstigations have exc luded interstitial patients from analysi s. therefore
compuisoosareDOl:posstble. Thestrong f3milialclUSlCring isp:d)abIydrivenby the diagnosisof
reawt~. V~reOwt palie:rtts acc:ounta1forO\'Cl'balfofthe imetstitialgroup
and evidencepoints to a geneticcausationin the deve lopm ent of renal failure for this etiology
(Bredin et ai, 1975; Dwoskin et el, 1976; DeVargaset ai, 1978; Icrkinsd al, 1982; Baily et el,
1984~ Haydenet al, 1984 ; Sirotaetal1986; Aggarwaleral,1989; Noe et a l,1992;Pcedcn et
a', I992).
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OfmlC:R:Sl wastbeobservancc ofa probandhaving ESRDsccondaty to reflux.who bad an
identical twin. Althoughboth the proband andthetwin badthesame type of reflux, only the
proband bad~ to renalfailta; showing the influenceof geoetic andenvironmental
interactions in the progression of renal deterioration. There have beenother reports of
vesicoureteral reBuxocc:UIringin twins(Stcpbens et a1,1955; Mebusteta! , 1972~ Hampelet al,
1975; Kierer ai, 1983; Haydenet al I984; Sirota et al, 1986).
rs
M I!iKoHiu.
l.iketbe etiologyofESRD itscJ..(, theproblem ofdl:termininga geoctic causationforrcmJ disease
iscomplex. 0bsc:rvaD0ns of familialconcentrations in the present study may bedueto genetic
resenblaece between relatives. to commoo environment or, as isprobablythe case. a mixtureof
both.Argument formuJtifactoriaJ lnhcritanceispiaUSlble. as it isbecorningmoreawan=ot thatmost
diseesesarencnp.aelygeneticorenvironmentalinetiology,butdependonacomplexinteraction
ofthcrno. AccoIdingtothemu1tifactoria1tbcory,ESRDisaoompJcx6nal~dctmnincd
by manyintermediate~ and euviromnental influences. There isa multi-invoI.vemem of
8""'"at U>depmdont loci which pr«tisp= the indivXluallO kidneydisease with environmcnta!
factorsinfiuencingexpression of thegene.Nomechanismof disease causationcan bediscerned
bythis~andtbcnumbcrandoatureoftbegmcsinvolvc:drcmainunknown.Evidence
sIXl'olI5 thatC'o'm forMendeIiaDdisordI:rs thereis cmsidefab&e CDVironmcnlal influenceon disease
occurrence(KlKuyel al, 1993). Many of thesesingle gene cooditions do not manifesI: clinically
at all, unlesstriggered by specific environmentalexposures (Gnmdjean et al, L99I). Eveuwith
<fu<ascsl:aU><'dhy_f8clOrs,,,,,,,,,",,,,,,,,,,,,bili!ymayhcinYcll><dindcl=>iningthe
ultimate clinical manifestations.
ThemajorstrcJgtbsofthecurrent studycompared to the~ous investigationson the familial
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basisofrmaldiseaseare the sizeoCIbcpopulationgroupstudied.1bcbomogeDooscxmposilion
oCmestudy populationandthefact that spouses~usedasc:ootroIs. This studydc:monstnItes
thatfust degreerelativesof probands witboutMcnddiaDdiseaseare at a three foldriskof ra18.I
failurec::ompam;l to tbosc of controls. The reported incidence ofES RD. registered with the
nationalregistries,istv.otimes higberin the rc:latiYesofprobands withESRDof~lian
etiologythanin the general population. Therenalfailwe rate of297/millionlyearfoundin first
degree relativesofprobands isapproximately four timeshighertlwt the ESRDrate fortheentire
NcwfoundlarxI population; higher than one \Wl.IId expect bychance. Onemustbe cmaious when
intcq::mingthe:scratcsduetotheincompkte~mcswithCORRon which tbepopuIation
rates are estimated. ThelnoompIete enrollmentbo....evershouldbeequalbetweenrelatives of
probands and controls therefore al lowing for a comparison between the t\loOgroups.
Sccooddegreerelativesofprobandshad the samerate of renalfailureas seconddegree rdatives
ofcontrol subjects (0.4%). Third degree reIativesof probands bad a higher rate thanthirddegree
rclativcsofoontroIs,butneehigherthanthefirstandsecond degreerelativesof oontroIs. Thebasis
forthislattcrobservat:ion is noteleal'". It ispossiblethatthe rarein thirddegreere~ofcontrols
isnotacrually as low as 0.2% given that a rate of 0.4% wasobserved in tim and second degree
re.lativesofcontrols. WecouidnotidcntUyanymetbodologica1erronthatcouldhaveinfluenced
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!hemesOlberthan umeIiabIe or inwIid iDfcJnnams. Thiserror isoctainly posgble for information
given ODsecond and tbirddegm: rt:latM:s sinoeconfirmationof rena.I filiIureby medicalm:on:15
wasnot done. Whenanalysis was donebased onthose registered with CORR a difference'MIS
observed in the p-oportionofsocooddegrcc rdative:s of probandsandcontrols who have ESRD.
One: can specula te that the failure to find a coocenttationof renaldisease in second de gree
relations,\Wile observing it in firstand thin:!degree reIatives. resultsfromrecessivegmetic liability
ina proportionoffiunilies increasing riskto, mparticular, cousins ofprobands. Longteemsecular
trendsindiagnosis and treatm ent ofESRD. anderrvironmental influences could result ina higher
proportionof~havingESRDcomparedtoseconddegreerelatives(Susscr.1987). Second
degreerelatives included llUDt'S. unc les andgrandparents. Most oftbese relatives belong to a
generation in which the availability to medicalservices in manyparts of Newfo undl and was
~E~ ifrmal disease was~ intbe:se reIatM:s it ishighlypossible thatadiagoosts
of renaldisease wastx:YeI' made.Third degr= rdatMs of iIdex casesarclargely cousins. These
indMduals belong to thesame gmoatiooas the Ud:xcase makingthelikelihood of diagoosis and
trcabnent forrenaldiseasemuchmoreprobable. Inessence,theeffcets ofenvironmental change
are observedwith thegeneticcomponents held constant
Evidenceforgeneticliabilityhasbeenaddressed fora number of common rena.I diseases. The
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present study'sfindingora risk ratioof3 .0 forthe presence ofrenal failureamong first degree
relativesof probandscan becompared withavalueof2.63 reportedbySprayet at(1995) in their
study of 103Caucasianfamilies. Theserisksare lower than the00dsratio0£9.1 observed fro
AfricanAmericanfamiliesfoundby Freedmaneta] in 131AfricanAmer1can families(1993B).
Steenland and associates ( 1990 ) studied 325 menwith ESRD and foundthat they hada family
histlxyofICJa1 failuremore frequeotlythancontrols(OR9.3; 950/0 0:8-10), althoughfemale and
diabeticpatiems~excludedinthisstudy. 5QOloofthispopulationwasCau:asian. Anobvious
explanationforthe lowerodds mba found in the current studyas compared to prior reports
(Freedman, 1993B; Steenland, 1990) is the differences in the etiology ofESRD in theAfrican
Americanpopulationstudiedby FreedmanetaJ(19938)versusthe Caucasianpopulation used in
thestudyandthe studyby Spray et a1(1995). Forexample., 21%ofthe African American study
group hadESRDattnbuted to hypertensivenephropathy, which appears to be among those
diseaseswithahlghe:rfamilial aggregation,wbileonly5%of (XObands inthecunentstudy and none
oftbe probands in theSpray study(1995) wereclassified as such,
The f8milial riskofESRD observed in thejnSCDt study and others mayootbedue to aninherited
predispo:sitiontoasingl.ediseaseentitybutlnstcadoouldbetheresuhofani:nherited~bility
to renaldamage. It is likely thatsusceptibilitywillvarybydisease process andby individual. In
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Freedman's study (l993B) on familial clustering ofESRD among African American families.
_fimUly""""""ofmultiplexESRDfiomili<s_bad_fiUl"",of_~
Members withinthcsame family hadESRDdiagnosed as the rcsultofhypertension, diabetesor
glomerulonephritis. freedmanetal (1993q proposes that the inheritedsusceptibility to ESRD
observed inAfricanAmericanswasa geneticpredispositionto microvascularinjury. Bergmanet
at(1994)reportedthat ESRDrelativesof patientswithhypertensiveESRDwereas likelyto have
diabetic nephropathy as hypertensive nephropathy. It seems reasonable to suspect a genetic
susccpllbilitytoprogressivcrcnal diseasethatisunrelatcd tothcprimary illness. The finalcause
ofESRDwouldthen dependon environmental exposures andothergenes . This hypothesis is in
line with thesuspicionsofseveral. investigatorsof diabeticnephropathy (Seaqui st et al, 1986 ;
Freedman et al. 1995A) andglomerular disease (Schmidt et al, 1990 ; Cusi et aI, 1993), who
propose thatthecontnbution ofgenetic factors in thedevelopment of renaldamagein diabetic
nephropathy, hypenensive sclerosis and glomerulonephritis ocCUJS independently of the
determinantsofimulin resistance and glomerular dysfunction. Indeed. the HI.A DRJ antigen is
increased among patients with diabetic nephropathy (Freedman et ai, 1993A). membranous
(Kloudaet ai, 1979; welchet al,1986; HuangetaI. 1989; Clerkeral, 1993; Sacks et al, 1987)
and hypertensive ESRD (Freedman et ai, 1991) . It may be a genetic propensity towards
hypertension. cardiovascular disease. andglomerular damage which in combination with
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environmentalexposuressuch as infection that determinesthe final phenotype.
There are a number oflimitations inherent in a studyof this type. It is recognizedthat not all
individualswith ESRDwillbetreated Untornmately, thesepeoplewillnet beaccountedfor inany
ESRDdatabases. Theaprarent fiunilial aggregation ofa diseasewillbe reduced iftherearea high
proportionof "sporadic" cases in the studypopulation This is almostcertainly the case in the
ESRDpopulation,giventhe heterogeneity ofdiseasesinthisgroup. Ingeneralcautionmustbe
exercisedwhen interpretingthe significanceoffamilial aggregationof disease.A highdegree of
familialaggregation ofanytrailby00 meansJXOve5 aninheritedcause. Conversely, a lowfamilial
riskdoesnotexcludean inheritedmechanism. Familial clusteringof renal diseasecouldbedueto
sharingofsimilarenvironmentexperiences duringchildhoodandadolescence, forexamplediet,
exercise habrtsandexposureto infection.all ofwhich can influenceprogressionto renaldisease.
Ifthesesimilarities included factors of importancein theetiology ofnephropathY theireffectsmay
mimicgenetic inheritance.
A relativelylowdegreeofassociationwith familyhistorywasobserved Theimplicationsof'the
odds ratio of 3.0 for renal failure in first degree relatives of probands compared to controls,
reported in thisstudy, maybejudgedbycomparing it to the reported fiunilial riskof otherchronic
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diseases whichmay or may not bedue to inheritedfactors (table 8). The mechanisms of the
diseaseslistedarenotkDJwn, butinheritedp-edisposition with5CHI1C type ofenviromnemal trigger
is hypothesisedin manycases. This study investigates a very beterogenousgroupof disorders
\Wichmayaccount for the low association observed Consideringthe etiologicheterogeneity and
patbologicdiversityofrenaldiseases it is ootsurprisingthataloWC'odds ratiois observed inthis
investigationcomparedto diseases such as AJzheimerand Parkinson's whichare clearlymore
"narrow" in their etiology. A lower oddsratio may also beaccounted for by the fact that the
phenotypicend point ofrena! disease- renal failure- wasmeasuredas the outcome variable.
Utilization ofanoutcomewhichoccursearlierinthecourseof the diseasesuchas raisedserum
creatinine , may have produced higher oddsratios.
Severalfactors complicatethe geneticstudy of rmaJ. disease. An importantproblemin interpreting
the current data is that of incomplete penetrancein which individuals may possess a liability
genotype withoutexpressing it(Weisset al, 1982~ Phenotypicmanifestationsofgenotype may
be reduced by variable expressivity and late age ofonset ofdisease symptoms. and gene-
environmentinteraction(Khoury et al, 1993). Theextent to whichgeneticand envirorunental
factors interact is hard to establish.
82
A limitationof thepresent investigationis the accuracyof the methodsusedto classifythecause
ofESRD. CMrall. someofthc classification isgoing to beettODCOUS., but it isdif6cult to estimate
bowmuch. Theimplicit undc:rlyingassumption fortbe multifactorial mode l forcommon diseases
is that any given disease has the same etiology (King, 1992). This is oot the case in this
investigation. The calculated oddsratio was based on a group of renal diseases which are
obviouslyindependent from oneanother in theiretiology. manifestations andinheritance. This
etiologicheterogeneity of renaldiseases complicates its geneticinvestigation. Thediagnostic
criteriaarenotmuttJallyexclusiveandthelimits betweenvariousdisease entitiesare not clearly
established. Diseases of discrete entities thatmay have different genetic andlor non-genetic
contributions have been lumped together under the same disease classification such as
glomerulonephritis and interstitial disease. A single disorder, such as ESRD or even
glomerulonephritis,is in reality not onedisease.but a groupofdiseases. Sucha broadlydefined
disordercan have a Dumber of differentsubtypes that are genetic or ecn-geoetic in origin. A
specific subtype may becaused bytwo or threeinteracting major genes,bya set of genes acting
in a polygenic pattern or by an environmental agent When the subtypes of a disease are
indiscriminately combined, the overall familial aggregation may not resembl e a genetic
predisposrtionorapsuemexpectedinmultifactorial inheritance.Renal artcIystenosisandesscntial
hypertensionare two such renaldiseasesthatwere allocated to the same diagnostic category
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d<5pnethetv.<><tiseascshaving_etiologjes,pbysioJogical df=mdclinical~
Similarly,many lnvestigato~considerESRDattributed to hypertensionto beanonspecific label
that is usedon patients with a variety of underlying kidney diseases (Weisstuch, 1992). The
accuracywith which other diseaseswereexcluded as contnbuting to ESRDwasoftennot clear
in thepatient's medical records. Thiswastrue for patients with diabetestype Il, Because the
diagnosiswasverysubjective~ is theproblemofmisdiagnosis. Misclassifical:ioo mayobscure
trueassociations.. Given the potentialfor error in classification ofthe cause ofESRD in the
probandit isdifficult 10estimatetheerrorsthatwould resultindcterminingthespecificfamilial risk
associated with any given disease.
ft could beargued that the clusteringofESRD in probands results fromdifferential~I. which
wouldbiasthe results in favourof probands. h is certainlyposS!ble that pWemson dialysiswould
bemorelikely to knowifa relativehadkidney diseaseandthusintroducea differentialreporting
bias. However.this is unlikelyforthc pn::sc:nt study, giventhatbothprobandsand controlsshould
becqua1lyawareoCtileprescnceofrenalfiliJ.um among thcirSlblings:and parents due to thesevere
nature ofthedisease. Evidenceshowsthat the uses of spousalcontrolsoffers several potential
advantages in the studyof familialdisease(Wickramatrie, 1995;Coughlin,1990; Drews. 1993;
King. 1992). Souses of patients with renalfailwe an:: likely to have considereda given fiunily
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disease to the same extent as probands andare tberetore less prone to recall bias. A positive
&miIyhistorywasconsidered basedon thedatagiven by theinformants. Because there wasno
verificationoftheac:curacyofESRDintberqxxtedfiunilymembertbissubjectivitycouldintroduce
anadditional sourceofrepmingbias.~. thisreportingbiasshouldbaveminimalaffecton
the riskscalculated as the biasshouldoccurequally betweenproband andcontrol families.The
aiteria usedto labela relativepositiveforrenalfailurewassimilarforbothgroupsand thedecision
wasmadebya single clinicalnephrologistwhowasblinded asto wbetberthe relativeinquestion
wasthatof a probandor control. Overall. reportingbias seemsunlikely tobe responsibleforthe
results reported here, especially for the results observed for first degree relati ves.
In the present study, theoutcome of interest- renal failure - often OCCW'S at the endof lifeor as
the final stageof renaldisease. Manypersonswith renaldiseasesuchas glomerulonephritisand
diabeticnephropathy do not progress to ESRD. This is true evenofMendeIianinherited diseases.
lndividuals withthegenotypeforADPKD. forexample"will all developcystsby theageof3O,but
onlya SOOIo chance ofdyingorgoingon 10dialysisby theageof5S (Parfieyetal. 1990). Identical
twinscanalsobeusedto dcmonstnne bowESRDmaybea poorgenetic marker forrenaldisease.
Theappearanceof a disease inone twin is probable, butfar from certain indicatorof itseventual
appearance in theother. Indeed,inthisstudy a pajrofidenti.cal twinswasobserved, botbofwhom
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hadvesicoureteral reflux.but onlyoneof whom progressed to ESRD. Fwthetmore, although
individualsinour studymay bave the geneticpredisposition to develop renal disease they may
succumb to otherco-morbidconditionssuch as heart failure, strokeor otherunrelateddiseases
beforeESRDoccurs. These persons are not accounted for in the ESRDdata base. Similarly,not
all persons whosufferESRD will betreated. As a result, ESRD maybea poormarker for a
geneticdefect, in that renalfailuremaynot occurinaUpeoplewho inheritthe geneticpropensity.
Ascertainingonlyfamilymemberswho hadESRDandDOtearliersignsofrenalimpairmentmay
seriouslyunderestimate thetotalpevaleoceofrenaldisease within families.Inonestudy ofpatients
withglomerular renaldisease, 1000ftbeir relatives bad.glomerulardysfunction.80010 ofindex
cases with affectedfamily relatives, werenot aware that this \WS the case until theInvestigators
discovereditwithclinica1screening(Rambauseketal,1987). BergmanandcollegesstUdiedthe
familiesof 40 black ESRD patients with a diagnosis ofhypcrtcnsive nephropetby. evidence of
nephropathywasfound in 39lirst degree relatives of26 of the indexpatients through clinical
screening. I 1of thefirstdegrccrelativeshadESRD. Thissuggeststbatthe familialrisk for renal
disease, at least glomerularand hypertensivedisease, maybehigher thansuspected. based on
case-controlstudiesemployingreportedfamilybistories. Perhapsifsomeothermeasureofrenal
dysfunction~ usedas a pUnaryoutoome,higherrisksoffiunilial rmal impairment wouldhave
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beendemonstrated in the present study.
Theappropriate: next step in the investigationof potential polygenicinheritance ofrenaldisease,
thereforeis to clinicallyscreenfamilymembersofindex cases for evidence of nephropathyat a
stage prior to thedevelopment ofESRD. Thefocus oftbe research should centre firston those
groupofrcnaldiseasesappearingtobebave in a familialpattern. In the present investigation. the
riskofESRD infirstdegn:e relativeswasbigbest in familiesofprobllndswithb:ypertensive ESRD.
interstitialrenaldiseaseanddiabeticnephropathy. Clinical invc:stigationoffamilieswithdiabetic
~""alreadydcnomlmredafumilial~onto<tiabotic..-.aldis<=(ScoqWst.
1989).In thisinvestigation, pttlenlS with reflwtnepbroptthycomprised thegreatermajorityofour
patientswithinterstitiaIdiscaseandthereisstrongexistingevidenceofgenctieliabilityforreflux
nephropathy. Todate.,littleclinicalinvestigationoffamilieswithbypertensiverenal diseasebas
been done. This investigation did sbow a familialtendency for renal failure in patients with
hypertensive renal disease . Clinical screening orfamily members from this group and an
appropriatecontrolmaydemonstratea higher riskof renaldisease. Observationof higher odds
ratioswould supporta moleculargeneticsapproachinaffcctod siblingsto identifywhichgenes
wereassociated with the trait,
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Giventhepresentswdy'sfindings andtbose ofotberiJM:stigators. the risk ofESRDnotattnbutable
to Mendeliancmditionsiswellworthfurtherinvestiglttion. EvaluationofrelenvesofpBtiems from
multiplex families maybeaneffc:ctM:meansofidc:ntifying individuals at increased riskforESRD.
Tbc identificat:ionofa highrisk subsetof individualscanbeimportant to an understandingof the
course of the disease andto assigning risk to individuals based on symptoms which may be
identifl<dthroughSlUdyingthcm A1though thegeneticaIIy~maycomprise onlyam>all
proportionofallcasesofa disease in the populationtheymaybea nwnericallyimportantgroup.
In the long run, screening family members may bean appropriate intervention strategy for
preventionandcontrol. This isespecially true for the groupof probandswhowereclassifiedas
havingESRDsecondaryto hypertensivenephrosclerosisor renovasculardisease. A substantial
proportion(44%) of the probands reported having anotheraffectedrelativewith ESRD. This
familialaggregationwasobserved to be~ thanthatobservedfordiabeticnephropathy, which
basbeenfotmdto havea strong familialcomponent By studyingspecific renaldisease more
closelyfordetectionofpossibleasymptomaticearliersignsofkidneydisease onecanreducethe
problem ofdisease heterogeneity with a more accurate estimate of risk.
Theaimoftbe present investigationwasthe establishmentofa moreaccurateassessmentof risk
forrenalfiWUICinsuscepClblefamilies. Wecoocludctbattbere is an increasedriskofreoal failure
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in firstdegree relativesof probandswithout a Mendelian inheritedrenaldisease in a Caucasian
popuIatioo. The"'"""""'tbnpoJygm;cU>h<ritaooe~ totbU~ ~ceminIy
plausible,with individuals inberitingapIlrticularcombinationofallelesandthusbecomingmore
genetically susceptible to developing a clinical co ndition. perhaps in response to additional
environmentaltriggers. The specificmechanismsresponsible for geneticsuscepllbility for the
majorityof thesediseases are not fullyunderstood or in anycasesnot known.. This ignorance:
represenatbe R2Ichallengefu<tbestudyoftbe.....,ncbastsofdiseeses, It~,.".".ny hopedtbn
molecularunderstandingof thoseaspect>of these diseases thathave genetic components will
improvetheirtherapyandallowfortbeir prevention. As moregeneticmarkersbecome mapped
throughthcHwnanGenomeProject. thetestingofcertainfamilieswithmultipicaffCClcdmembeB
mayreveal. the genomicregionsmost closelylinked to thedevelopmentof kidneydiseases such
as diabetic nephropath y, glomerular andintersti tial disease (Brosius et al, 1992).
TABLES
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Table I. Cba racteris tics or Baseline Patien t Population
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Mean Age (yrs) startin g ESRD treatment
Median Age (yrs)
Rang,
MaIe(%)
ESRD Oassification
Glomerulonephritis
Diabet es Mellitus
Interstitial Disease
Hypertensive Nephrosc lerosi s
Polycyst ic Kidney Disease
Mendelian Disease
Oth"
Multipl e Causes
Unknown
TOTAL
Treat ment Fadl ity
Health Science Centre
Salvation Army Grace General Hospital
Western Memorial Regio nal Hos pital
CORR Registration
V"
No
50 .1 ±. 19.2
53
(2- 87)
62.9
~ .%
168 25.1
lJJ 19.9
70 10.5
34 5.1
30 4.5
27 4 0
85 12.7
28 4.2
'M 14. 1
•••
398 59.5
190 28.4
81 12.1
471 70.4
198 29.6
Table 2. Mendd iaa Diseases Lading to ESRD in BaJelioft Popul ation
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N
Autosomal Dominant Disuses
0"
Genetic:
%
Tou l
TOTAL 11
57
Polycystic Kidney Disease
Charcot-Marie-Tooth Disease
Autosomal Recessw e Diseases
Bardet·B iedl Syndrome
2, 8 Dihydroxyadenine Syndrome
HyperoxaIuria
Caroli Syndrome
Alport's Syndro me
30
2
52.6 45
3.8 0 3
3.5 OJ
3.5 0 3
3.5 0.3
1.8 0.1
3 1.6 2_7
Tab le 3. Cause ESRD in Pr obands without a Single-Genc
Inheritance for their ESRD
N %
Glomerulonephritis
158 29.7
Diabetes Mellitus
Diabetes mellitus type I 50 9.4
Diabetes mellitus type II M ll.2
114 21.4
Interstiti al
Reflux 32 6.0
Nephrolithiasis 12 2.3
Tuberculosis 7 1.3
Unspecified JJl 1.2
61 11.5
Olber
Obstructiveuropathy 22 4 .1
Autoimmune diseases 16 30
Malignantdiseases 12 2.4
Latrogenic 8 1.5
Miscellaneous causes II 1.1
71 11.9
Hypertensive Neph rosclerosis 26 4.9
Multipl e Causes 25 4.7
Unknown ii 14.5
TOTAL 532
92
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Table 4. Numb er and Proportion of Probands (0=530) and
Controls (0 "" 494) who have a Fam ily Mem ber with ESRD,
with Odds Ratios and 95 % Co nfidence Intervals
Degree of Probands Controls Odds 95°/. CI
Relative Ratio
• of IPrebends • of I% Control,
Probands with Family Controls & Family Hx
Hx of ofESRD
ESRD
First 63 11.9 14 2.' 4.63 2.52·9 .01
Second 48 9.1 45 9. 1 1.00 0.64- 1.56
Third 44 8.3 14 2.8 3.11 1.65·6 .22
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Table S. Number aDd Percen tage orFi n t, M-cond aad Thin! Degeee
Relatives wit [SRD Amo ng Prob.aads aDd Contro ls.,with Odds Ratios
aDd 95% Confidence Intervals
Degneof Proba nd, Conlrols 0'''' 95% CIRelative Ratio
Number of I ESRD in Nu mber of I ESRD in
Relatives RelatiVe! RelatiVe! Relatives
First 5780 67( 1.2) 3807 IS (0.4) 3.0 1.7- 5.2
Second 15475 58(0 .4) 12093 53 (0.4) 0' 0.6- 1.2
Third 13194 49 (0.4) 11617 21 (0.2) 2.1 1.2-3.4
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Table 6. Fera nlage or Affect ed Fi rst, S«ODd. a nd Thi rd Degree
Reialiv es witb £S RD Attor-ding to Etiology or ES RD in Pro balld
Etio logy or ESRD i ll % Fint~ % Seco nd ·;"Third~
Pro baad Relativa I)qrft Relatins Relati ves
Glomeru lonephritis 0.76 0 46 0.22
Diabetic Nephropa thy 1.35 0.26 0.3 1
Interstitial Disease 1.42 0.2] 0.94
Hypert ensive 2.47 0.69 0 44
Nep hros cle rosis
Multiple causes 0.7 1 0.12 0 .68
Olh er 0 .81 0.21 0.65
Unknown 1.25 0.4 1 0.4 1
Tab le 7. Comparison of Prob aods and Controls for Number of Fint, Second,
and Third Degree Relatives with ESRD who are Rrgisl ered with C ORR
Rela tion Proba nd! (%) Cont ro ls (0/0)
First Degree Relativ t!!
alive >198 1 4407 2846
ESRD & CORR registered 17(0.4) 5 (0. 18)
Second Deg.-ce Relatives
alive > 198 1 11910 9239
ESRD & CORR registere d 14(0.12) 4(0.04)
Thi ...d Degree Relativ es
alive > 198 1 11379 10378
ESRD & CORR registered 14 (0,12) 5 (0 .05)
Fir st - Third Degr ee Rela tives
alive > 1981 27696 22463
ESRD & CORR registered 45 (0 .16 ) 14 (0.06)
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Table 8. Odds Ratios an d 93% Confidence In terv al! of Having
Affected Fint Degree Relatives in Su bjec:ts Diagnosed with Different Diseases,
Pr oba nds vs. Controls. in P ublished Case-Control Studies.
Whe n the lower Confidence Limit is >1.0 the Odd s Ratio is Signi fic:antly Increased.
95°/. Confi dence Interv al Not C alculated
Disease Auth or and Year Number of Contr ol Type Odds Ratio
Subjects and Number (95% C.I.)
100 M Dalqui st c:tal .• 1989"'9 339 population (528) 7.8(3.6-16 .8)
Alzheimer's Amadu cei et al., 1986 50 116 hospital ( 116) 50"
Disease population (97) 2.6'
Chandra et aJ.• 198711 64 hospital (64) 1.0"
Graves etal .• 1990' : 130 popuIatio n(130) 2.2( 1.17-4. 18)
Multiple Midgard ct al., 19%SJ 155 hospital (200) 12.9(1.73-552)
Scleros is
Migraine Stewart et al.• 1997" 73 population (72) 1.5(0.94-2.40)
Head aches
Atopic Eczcma Diepgen et al., \ 996 sS 426 population (62 8) 2.2( 1.58-2.%)
Parkinson's Payami et al., 1 994~ II ' popul ation ( I 14) 3.5 ( 1.3- 9.4)
Disease
Marder etal.• 1996s7 233 popul ation ( 1172) 2.3( 1.3 -4.0)
Rheumatoi d Jones etal .• 19% '" 207 population (180) 1.6(0.3 · 8.7)
Arthri tis
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A. Initial letter to inda patient
Dear
We are interested in learning more about bow kidney disease tcnds to run in families.
Since you have been affected by diabetes. I would ask for your participation in a research
studyto identify other family members with diabetes, kidney disease or high blood pressure.
A research assistant will becontacting you by telephone during the next few weeks to
ask if you would be willing to participate. Your participation in this study is entire ly voluntary .
You may not decide to participate or may withdraw from the studyat any time.
With your permission. she will ask you questions about your immediate fam ily's medical
history. These questions wi ll focus on whether any other family members have beendiagnosed
with a diabetes. kidney disease or high blood pressure. The interview will last up to 20 minutes .
A mutuall y convenient time for this interview can bearranged. Ifany family members are
identified as having diabetes. she may ask you to co ntact them for permission to allow her to
co ntact them for information andto arrange a time where clinally investiga tion of renal function
canassessed throughurine tests .
Your participation woul d begreatly appreciated.
Yours truly,
Dr.Hamott,MD
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B. Initial letter of contact to index patient's fa mily
We ate interested in learning more about now kidney disease tends to run in famili es .
Since you have hada family member affected by kidney disease , [ would ask fOT your
participation in a research studyto identi fy other family members with kidney disease or high
blood pressure .
A research assistant will becontacting you by telephone during the next few weeksto
ask if you would bewilling to participate. Your panicipation in this study is entirely vo luntary .
You may not decide to participate or may withdraw from the study at an y time.
With your permiss ion, she will ask you questions about your immediate family's medical
history . These questions will focus on whether any other family members have beendiagnosed
with a diabetes , kidney disease or high blood pressure. The interview will last up to 20 minutes.
A mutual ly convenient time for this intervi ew can be arranged. Ifany family members are
identified as having diabetes, she may ask you to contact them for permission to allow her to
contact them for infonnation and to arrange a tim e wher e clinical investigation of renal function
can assessed thro ugh urine tests .
Your participation would begreatly appreciated.
Yours truly,
Dr.Hamett.MD
C. Questionaaire Checklis t
FromInICrViewee
I."""""
2. FGher's name
D~olbirtb
_of""",
... of""'"
yearofdcalh(die~19801
Historyofrenaidise&se,hypenension,diabeb::I
Cornmllllityofbinh
3. FlIlher'spannl'snames
DlIkofbinh
_of""",
ageofdesrh
r__ ofdeath(die before l980)
Himry of renaldisease, IlyperteftsioD, diabetes
1. Falhets$l.lllinp(indudinghalfsib1ingsandinfantdealhs)
Dtaeofbinb
Living
_of""'"
ageofdeath
yar ofdeal:b.(die before1980)
HistDryofraW-diseae,bypenension,diabetes
NumberofchildRn 8lld theirgender
UW>a
_of""",
agtlofdealh
yesroldealh(diebefore I9S0)
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6.Mod1er'sllllllle
Dceofbirth
"""" _or......
... or......
yeuofdedl(diebefure 1980)
HislDryofrenaldisease,b:ypenc:PSioD,diabell:S
Comml&lityofbinb
7. Mocbe(sparem'SIl&llleS
DlIleofbirtb
_or......
ageofdesth
year ofdech (die before1980)
Hisloryofretl41disease,lIypertension,diabetes
8. ModJer'ssiblings(irlclvdinahalfsiblingsaodinfurtde8lhs)
DlU:eofbirth
_or......
... or......
yearofdeab (diobefore1980)
HislOf)'afm181disease, Irypenension.diabetes
Numberofehildrel'llndtbeir~
""""eauseofdech
ageofdeslh
yearafdeath {diebefore I980)
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9. Propositus' sibling5(indudmghalfsiblingsllIldiPfantdeadJs)
N_
DlIIeofbinh
_or....
... or....
yearofdeslh(diebefinl980)
Historyof rmaldisease,hypenmsion.diabeM
NwnbeI"ofcbildren
l.Mog
_or....
ageofdeattl
yw-ofdeldt(diebefore I980)
Hi$toryofrenaldiseGe,bypenensim.diabetes
10. Propositus'ebil dreninorderofbintl
N_
Dldeofbinh
l.Mog
_or....
... or_
yeacofdeam (die before1980)
Historyofrenaldlsase,h)'pettension,diabetes
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F. The Importanceof Renal Impairment in the Natural History of
Bardet -Biedl Syndrome
INTRODUCTION
Bardet (Bardet, 1920), in 1920. andBiedl (Bied! , 1922) , in 1922, described a syndrome
characterised by congenital obesity , polydactyly , retinitis pigmenrcsa, mental retardation and
genital hypoplasia. In 1925, Solis-Cohen andWeiss (Solis-Cohea, 1925) mistakenl y
combined this syndrome with a disorder . described by Laurence and Moon (Laurenc e. 1866)
in 1866, into one syndrome known as the Laurence-Mocn-Biedl Syndrome (Solis-Cohen,
1925). Today, Bardet-Biedl Syndrome and laurence-Moon Syndrome are recognizedastwo
distinct disorders (McKusick, 1992~ Editorial. 1988). Whi le polydactyly is frequent in Bardet -
Biedl syndrome it is almost absent in the rarer Laurence-Moon Syndrome. As well. neurologic
complications observedin Laurence-Moonsyndromeare not observedin Bardet- Biedl
patie nts (McKusick, 1992; Editoral, 1988; Schachat et el, 1982). Rece nt stud ies suggest that
the cardinal manifestations ofBardet-Bied1 include not onJy n:tinal dystrophy, obesity ,
dysmorphic extremities. hypogenitalism in males. but also renal abnormalities (Green et el,
1989). Other anomalies observed frequently in this rare autosom al recess ive condition include
mental retardation, hypertension and diabetes mell itus (Laurence, 1866; Green et al. 1989; Bell
et al, 1958; Escallon et el,1989).
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In the past the care of patients with Bardet-Biedl Syndrome hasnot beenoptimal , particularly
because oftheir abnormal appearance, incapacitating blindness. and assumed mentaJ
retardation. Thesepatients may survive to adulthood and then present to nepbrologists with
hypertension. abnormal renal imaging tests, or renal failure . However little information is
available concerning the natural history of affected individuals and the importance of renal
disease in their clinical outcome. Therefore we have re-evaJ.uated Berdet-Biedl patients studied
in 1987 (Green et al, 1989), and have investigated additional Bardet-Biedl patients identified
since the original study. This paperreports on the age ofdiagnosis of important clinical
manifestations including blindness, hypertension. diabetes mellitus, renal failure and death. and
compares the frequency in patients andtheir unaffected Siblings.
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METHODS
In our originalstudy , 32 patients with Bardet-Biedl Syndromewere identi fied throughthe
registry ofthe Canadi an Nationallnstitute for the Blind (CNIB), records in theOphthalmology
Department at the Health Sciences Cen tre , St John 's, Newfoundland, and through subseq uen t
famil y studies (Green et al, (9 89). Medical reco rds werealso searched to identify any persons
receiving treatment for Bardet-Biedl or Laureo ce -Moon -Biedl Syndrome. A further 6 pati ents
were ide nti fied since 1987. Thus 38 patients from 21 fam ilies with Bardet-Biedl Syndrome
were studied. Consanguinity was knownor assumed in 7 families. t9 were female and 19
male. with ages rangingfrom 1..63 years at last followup. with a mean ageof35 ±.IS years.
There were 58 unaffected siblings in the 21 familiesand a further 6 infant deaths in whom
Bardet-Biedl diagnosis could not be ruled out 28 ofthe sib lings we re female and 30 were
male . The ages of the sibli ngs ranged from 7-59 . with the mean age being 38 ± 10 years .
The geographic distribution of famili es with Bardet-Biedl Syndrome is shown in Figure 1.
260 ,000 people live around the Stjohn's area andthe remaining 300 ,000 are distributed in
coastal communities around the island. Until recently contacts betweenthe communi ties were
by the sea. as there were few roads . The resul t of this iso lation bas bee n a clustering of many
recessive conditions in certain pansof the island. where consanguinity is likely to behigh. The
families with Bardet Biedl Syndrome, however, werefound to be scattered all over the island..
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A protocolfor invest:igatioa was approved by the Human Investi gations committee of St.lobn's
GeneralHospital. For those patien ts undergoing evaluation an appropriate informed consent
wasobtained.
17 patients with Bardet-Biedl Syndrom e who werefully evaluated in 1986fJ were re-studiedin
1993. A further IS patients bad complete evaluation in ei ther 1987 or 1993, and the remaining
6 patients bad putial testing. 4:5of the S8 unaffected SlDlings were avai lable for com plete
testing in 1993. 1D addition. medical recordswerereviewed for all 38 cases aDd4:5 of thc
unaffected siblings to obtain co nfirmation of information co ncerning age of onset of legal
blindness, hypertension. diabetes mellitus., renal impairment andendstag e renaldisease .
At each visit blood pressure wasrecorded Blood wasdrawn for measuremen t of serwnurea,
creatinine. electrolytes., glucose , g1yrosylatedhemoglobin. calci um. alkaline phosphatase,
albumin. total prtKcin, bemogIobin, com plete blood count. Blood was alsoobtained for
measuremen t of follic le stim ulating hormo ne (FSH). luteinizing hormone (l.H), pro lactin.,
testosterone andestradiol. Urine sam ples were obtained and analyzed for blood and protei n.
29 Bardet-Biedl patients underwent ultrasound ofboth kidn eys. with 21 having serial studi es
available. all of these being interpreted by one radio logist (BeC). Unaffected siblings did no t
undergo ultrasound investigation.
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The height and weightof27 (15 female , 12 male) adult Bardet-Biedl patients and 42 (21
female, 21 male ) adultsiblings were convened to Body MassIndex scores (BMI) based on a
formula which integrates height (m ) and weight (kg ) (Healthy Weight. t987).
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DEFINITIONS
Ramel-Riedl Syndmrp;: the presence of dystrophic extremities ± polydactyly. retinal
dystrophy and obesity , in the absence of neurological complications. Other manifestations
include genital hypoplasia in males. mental retardation. andrenal structural abnormalities, but
these were not incorporated into defining a case .
~: sitting systolic pressure > 150 and/or diastolic >9OnunHg or taking anti-
hypertensive agents . Age of onset ofbypertension wasconsidered to be the age at which the
first record ofbypenension was observed in the medical charts.
Renal jmnainnent: estimatedcreatinineclearance of less than 1.2 mlIsec(70ml/min). using the
formula of Cockroft and Gault (Cockroft et al, 1976), or a serum creatinine > 120 j.Ull.ol per
litre (1.35 mgldl) when creatinine clearance values werenot available (2 not available). Age of
diagnosis of chronic renal failure wastaken to be the earliest recorded date of rena! impairm ent
Diabetes me!!jtwr glycosylated hemoglobin levels above the upper nonnallimit 0£0 .07 or
presently on a therapy (diet, drug or insulin) to control blood sugar levels . Age cfcnset of
diabetes wasdetermined from the earliest clinical recording in the medical records .
~: BMIgreaterthan27(+, 1987).
~: visual acuity of2anOO or less, or a visual field of 20 degrees or less.
Primary testicular fpjI'Ire: serum testosteron e levels below lower limit of normal with FSH and
lli levels above the upper limit of normal .
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Primary ovarian fajlu!Ji; serum estrogen level s below lower limit of normal with FSH and LH
levels above the upper limit of'normal, in females of reproductive age. corrected for time in the
menstrual cycle at which blood was taken.
ISO
SfAnsnCAL ANALYSIS
The Kaplan-Meier method was used to com pare ageof diagnosis of various clinical
manifestations in Bardet- Biedl patients andtheir unaffected SIblings (Dixon. 1988). TerminaJ
even ts included death.chronic mJaI failure,. blindness. bypertension. anddiabetes mell itus.
T wo tail chi sq uare tests wereused to compare proportions. Fisher's exact test wasused for
evaluating statistical differences for of ce lls bavin g observ ed or expected frequency of less than
S. Differences in the quanti tative vari ab les were evaluated by student's unpai red t-test . P
values less than0.05 wereconsidered significant.
The total numberofpatieuts studied varied for the differe nt investigations.
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RESULTS
The mani festations ofdisease present in Bardet-Biedl Syndrom e are presented in Table I. The
earliest mani festati ons are those associated with dysmorpbic extremities Including polydactyly,
syndactyly and b<3<:hydactyly.
~: Of36 patien ts with Bardet-Btedl Syndrome 86% werelegall y blind. as compared to
none oCthe 45 siblin gs eva luated. Since the BSS pati ents were ide nti fied primaril y through the
CNIB a possible bias may exist. Theblindness was usuall y incapac itati ng. At last exam ination
one patient bad 00 light perception. 28°4 (N-7) co uld perceive only light, 16% (N-4) could
see only had movements. 28% (N -7) coul d do no better than count fingers . The remaining
24% (N-6) badvisual acuity.::s 201200. Theage rangeof n::cordcd legal blindnesswu
5·29 yeatS of age. Figure 2 shows that 25% ofBatdet- Biedl patients werelegally blind by the
age of 13, SO%by theage of 18 and 100% by the age of30 . All five Bardet-Biedl ~ents DOt
yet:legally blind were under theage of 12 years. Retinal dystrophy wasobservedin 100% of
rna patients. For other ocul ar abnormal ities see Gree n et aI (Green et al, 19 89).
~; 66% (25/38 ) of Bardet- Biedl patients werehypertens ive co mpared withonly
11% (5/45) of the unaffected siblings. 60% of the hypertensive Barde t-Biedl patients were
treated with antihypertensive agents . 25% ofBardet-Biedl patien ts bad elevated blood
pressure by the age of26. SO%by the age of34 and 75% by theage orS) (figure 3). In
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contrast, 25% of unaffected sibl ings were bypertensive by the age of 49 (p = 0.00 1).
Diabetr§ Me!ljU!,: 12 out of38 (32%) Bardet-Biedl patients investigated haddiabetes me llitus
compared to none of' the 45 unaffected siblings. Two patients were insulin dependent. four
wereprescribedoral hypoglycemic agents and 6 were maintained with dietary management
Figure 2 shows tha t 25% ofBardct-BiedJ patients werediabetic by the age DO S and 50% by
the age ofSS. The ageof diagnosis ranged from 24-55 years .
~: Renal impairment occurred in 9 of36 (25% ) patients. 4 of whom progressed to
end stage renal disease. The earliest age ofonset observe d was2 years old By age 48, 25%
of Barde t-Biedl cases hadchronic renal insufficiency (Figure 2). Only I unaffected sibling bad
mild renal impairment
Rena! Structure: Fetal lobulation was present in 96% oC28 Bardet-Biedl patients investigated
with ultrasound. abnormal calyces in 96% , calyceal diverticula or cysts in 58% of patients,
diffuse cortical loss in 25% and focal cortical loss in 70..11. In three patients with renal
impairm ent at the time of last ultrasound. 2 had di ffuse cortical loss and I (4%) hadfocal loss .
Of2S patients with normal renalfunction at time of ultraso und 1 hadfocal loss and 5 (20% )
had diffuse cortical loss. two of whom showed progressive loss on serial ultrasound
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Survival Analy§i$~ 8 of38 (21%) Bardet-Biedl patients died by last follow up(3 males,5
females). The ages ofdeath ranged from 1-63. Three(38%) oftbese deaths were the result of
End Stage RenalDisease(ESRD), 2 from congestiveheart failure both ofwborn hadchronic
renal failure , I from metastatic renal cancer who also had cbronic renal failure, I from
pulmonary embolism andmorbid obesity, and the 8th from respiratory failure andsepsis
following surgery for Hirscbspnmg'sdisease at age I year. Thus renal failure waspresent in
75% of patients at the time of death.
Gfthe 58 unaffected siblingsonly one (1.7%) haddied (as a resultoCa myocardial infarct at the
age 36) .
Figure 4 shows the cumulativesurvival in 38 Bardet-Biedi patients and their 58 unaffected
siblings. Life expectancywassignificantly worse in patients with Bardct BicdISyndrome than in
their unaffected siblings with 25% of Bardet-Biedl patients dead by the ageof44 years ofage
(p<O.OOOl).
~: Figure.5 showsthe distribution of BodyMass Index in affected and unaffected
Siblings. The range orBM! for female Berdet-Biedlpatients was30-55 (mean 4O.1:t8.3)
compared to 2040 (mean26..5;t5.14) for unaffected female siblings. Female Bardet-Bicd1
patients bad significantly greater BMI compared to their affected brothers (p<O.Ol). For male
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Bardet-Biedl patients.the 8MI ranged from scores of2I~S5 (mean 33±8 .1) compared with
2Q.42 (mean 29.I±S.2) for their unaffected male siblings. The obesity in Bardet-Biedl patients
was responsive to calorie restriction, as 5 patients lost subswl.tial amounts of weight on calorie
restriction diets .
GonadaJ Dysfunction: During the study 10 males hadtests of gonadal function 4 ofwbom bad
evidence of primarytesticular failure . One of the9 females of reproductive age (excluding 3
being treatedwith contraceptives) hadprimal)' ovarian dysfunction.
Menm! Retardation : Forty-one per cent of the patients were considered mentally retarded .
Funher details of objective IQ testing can beobtained from Green et al (Green, 1989).
DISCUSSION
Bardet Biedl Syndrome is a rare disorder . The incidence rate in Switzerland is I in 160,000
live births (Klein et al, 1969). Among the mixed Arab population of Kuwait the prevalence
rate is estimated at 1:36,000. However. among the Bedouin in Kuwait. where consanguinity is
frequent. the rate is estimated at I:13,.500 (faraj et et, 1989). A similar prevalence rate bas
been observed in the Newfcundlend population (1:17,500) (Green et al. 1989). The sca tt ered
geographic distribution of the families we studiedis striking, unlike the clusterin g often seen in
autosomal recessive conditions.
Prognostic data for Bardet Biedl Syndrome is of particular interest to families withaffected
individuals or at risk of having children with the syndrome , as well as to physicians who must
advise and treat them becauseof the serious clinical manifestationsand the lackof
demonstratedpreventive therapy.
Polydacty ly and/or syndactyly is the earliest manifestation of the syndrome and is recognized at
birth. A dela y in achieving developmental milestones may be expected in many affected
individuals due to mental retardatio n or decreased vision (Gree n et al,1989). Obesity is
frequently presen t in childhood. Blindness usually deve lops in the teen years. In early
adulthood hypertens ion. diabetes mellitus and renal failure occur . Longevity is substantially
reduced
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~ This manifestation usually begins in childhood and increases in severi ty wi th age (Klein
et al, 1969; Dekaban et al, 1972; Bauman et al, 1973) . Bauman et al (1973) reviewed 73
cases where birth weight and subsequent weight gainwererecorded in order to better define
the age of onset ofobes ity . 71% ofBardet Biedl patients were>5Oth percentile at birth with
38% being >9Oth percentile. For those that were above the SOth percentile at birth. 33% of
these cases were obese by one year of age . Thi s adiposity noted during ear ly life hasusuall y
been described as diffuse andnonspecific in distribution. By adulthood, howe ver , this adipos ity
becomes the most prominent in the trunk and proximal secti on ofthc limbs .
.6l.indIlw: Severe retinal dystroph y is another feature presenting ear ly in affe cted individuals.
The earliest mani festation of retinopathy has beenobserved to be eithe r loss of central visual
acuity and or decreased night or peripheral vis ion (Scbachat et al, 1982; Jaco bson et al, 1990;
Leys et ai, 1988; Fulton et al, 1993; Riise et al, 1987 ; Lyle et al, 1946 ; Krill et aI, 1961).
Retinal dege neration leading to blindness has been reported to appear between the ages of 4
and to (Dekaban et ai, 1972; Krill et al, 1961 ; Campo et al, 1982) with 73% ofeases bein g
blind by the age of20 (Klein et al, 1969). Other studies have found that visual acuity was
moderately reduced at the beginningof their teens, after which it rapidly decreased by the age
of 30 (Jacobson et al, 1990; Leys et el,1988; Riise et el,1987; Campo et al, 1982).
Deterioration of eyesight occurred rapidly in om patients with 2.5%of Bardet-Biedi patients
being legally blind by the age of 13. 50% by the age of 18 and 100% by the age of30. The
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wide nmge in agesofdiagoos is oflegal bliDdness(ages 5-29) observed in our patieots may be
the result of late or inaccurate~g of preci se ageat which individuals were legal ly blind.
This may beparti cularl y true for older patients . Theseveri ty of blindness is often incapacitating.
as demonstrated by the fact that in 76% of peaenrs examined visualacuity wasat the level of
counting finger.; only o r worse .
~: Hypertension wasobserved frequently and at young age in Bardet- Biedl
patients. 5Ol'tO affected by age 34 yean . It is difficult to know whether hypert ensi on is a direct
result arthe mutant gene , or an indirect result of renal involvement, obesi ty or diabetes mellitus.
pjab!;tes meJ!im5~ A higher rate of diabetes wasobserved in our groupof pati co ts (36%) than
in those studies by Amman& KJien (l4 %) (KIeinetal.I969 ). ThisabnormaJ ityin glucose
metabolism occurred earl y, with 50% of our Bardet -BiedI patients deve loping diabetes mellitus
by the age ofSS. Thecause of diabetes in Bardet-Biedl patients remai ns unclear. Pancreatic
histological abnormal ities have not beenobserved in autopsy reports to account for the
prese nce ofabnonnal glucose levels (Fraccaro et al, 1953; Franke, 1938 et at; Churchill et aI.
1981) . Obes ity co uld lead to the development ofdiabet es by a reduction oftbe cell ular insulin
receptors, which in tum leads to a decrease in insulin sens iti vity andan increase in insulin leve ls
(Ri.z:zaet al, 1981; O lefsky et aI. 1981). Diabetes in Bardet-B iedl syndrome is probably type 0
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diabetes because increased insulin levels havebeenreported followinga glucose load in
Bardet-Biedlsyndrome (Gree n et al, 1989)andonly 2 of the 12 Bardet-Biedlpatients with
diabetes were insulindependent Therefore it is likely that dietary management would be
helpful . at least in the initial phases,
Rena]Impaixment: Renal disease is a chatacteristic feature of the syndrome(Green et al, 1989;
Harnett et el, 1988; Churchill et aI, 1981; AlIon et at, 1913; Hurley et al, 1975; Tjeder et ai,
1982. Linne et al, 1986). Structural renal abnormalities have been observed in up to 100%of
patients reported in recent clinical series (Hamen et al, 1988). The radiographicobservations
of fetal lobulation,calyceal clubbing, blunting.cysts Of diverticula. in our Bardet-Biedl patients
are characteristic of tho syndrome. Twen ty five percent ofpatients had impaired glomerular
filtration rate and in the group with nonnaI renal function a further 20% haddiffuse cortical loss
on renal ultrasound. One suspects that the latter group will go on to develop renal impainnent
Impairment of glomerular filtration rate often occurredat an early age. By the age 48 years
25% ofBardet-Biedl patients had renal impairment The earliest age of onset of chronic renal
impairment wastwo years of age . Case studies(Tieder et al, 1982; Bluett et al, 1977; Linne et
al, 1986) have shown even earlier onset of chronic renal failure, with a 3 month and 6 month
old infant developingchronic renal failure.
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~: There are no reported data on the life expectancy of'Bardet-Biedl patients.
Longevity is certainly reduced. with 25% of individuals affected with Berdet-Biedl Syndrome
dying by the age of44 compared to only 2% of unaffected siblings. Renal failure has been
observed to be a frequent cause of death. (Klein et al, 1969; Churchill et et, 1981; Nadjimi et
al, 1969). A review of 16 autopsies by Churchill et at showed that 56% ofdcaths resulted
from renal failure (Churchill et al, 1981). 380/, of the deaths observed in our study were the
result of chronic uremia anda funber 38% of patients had rena1impairment at time of death.
The early onset and severity of the various manifestations oftbis syndrome make early diagnosis
of the syndrome essential if the patient's function is to be maximized. Only the feature of
dysmorphic extremities may be recognizedat birth. However. the presence of retinal
dystrophy, severe obesity andrenal structural changes should lead to an early diagnosis. The
fact that many patients are not mentally retarded(Green et al, 1989) and do not become blind
until their teen yearssuggests that special education could maximize patients ability to function
independently in adulthood. Screening for hypertension. abnormal glucose levels and renal
function is indicat ed, as early treatment ofthesc manifestations could bebeneficial.
~: Swift and Croft (Croft et al, 1990) have postulated that heterozygote siblings of
Berdet-Biedl patients are at an increased risk of also developing obesity, hypertension, diabetes
andrenaldisease, This is based on the frequent observation of these complications in a review
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0£75 relatives of2 Bardet -Biedl patients . Other studies also reporton unaffected family
members with obesity (Ehrenfeld et at, 1970) andrenal impairment (Runge et al, 1986).
Although 57010 of unaffected siblings in our stUdy had a body mass index greater than 27 and
25% of unaffected siblings were hypertensive by age 49 yean. only one bad mild renal
impairment, none:bad diabetes mellitus and there wasonly 2% mortal ity by the age of50.
The rate of'hypertension may be artificially elevated in the unaffected siblings because they were
assessed only once, as part of the study . In a group ofautosomal dominan t polycystic kidney
disease families studiedin a similar manner we observed hypertens ion (as defined in the current
study ) in 23% of unaffected adults aged 40-59 years (Parfrey et aI, 1990). It is possible that
on repeat testing blood pressure may not remai n elevated
At present the evidence to support an increased risk ofclinical ly important disease: in
heterozygo te siblings is not strong.
~ Bardet-Biedl syndrome hasan adverse prognosis with early onset of obesity ,
blindness, hypertension and diabetes mell itus. Renal impairment is frequent and an important
cause of death . Survival is substantially reduced.
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TAble 1: Cllnk.aJ ~niffStl.tJont of IArdtt-lltdi Syndrome.,
N N
'"Wolh Eumined
A!lncnN1l1y
Syndoclyly0< po/jdodyIy' 29 11 93
Po/ydaclyIy' 18 31 sa
BrachydKtyty 01'.... 22 22 100
L...llybUnd 31 36 16
Severe bHnd...... 19 25 16
Reti...1dy>b<lphy' 28 28 100
-"'entalmardiliOtf 1) 32 41
Obesily 25 21 93
Hyposenitalim.in men 18
PritNtYtesticular~i1ure 10 40
PritNtYOYiIIrian failure 11
Diabetesmellitus 12 ]I 32
Hypertension 25 ]I 66
Reduced IIometuIM
liltntion Rte 36 25
RenalfetAl lobulation 21 28 96
AbnorrNl renalcalyces 21 28 96
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